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“Dave, what you need to understand is that graduate school is a transitory phase,” 
my advisor, Andrés García, would often explain to me.  As my time at Georgia Tech 
draws to a close, I am realizing the full truth of this statement.  And as life-phases go, this 
has been an amazing one that would not have been possible without the help, guidance, 
and support of a number of people.   
First I would like to thank Andrés, whose contagious passion for science and 
unwavering belief in my abilities inspired me throughout my tenure as a graduate student 
in his lab.  I will miss his impromptu visits to my lab bench, his passion for all things 
spinning disk, and his willingness to engage in scientific discussions, day or night.  
Andrés provided me with direction and at the same time gave me the freedom to explore 
my own scientific curiosities.  I am especially grateful to Andres for putting up with my 
mood swings and (often unfounded) pessimism.  I‟m sure there were plenty of times 
when he thought twice about picking up his phone when he saw I was calling .  In the 
end, he was right when he told me the hard work would pay off.  But hey, that‟s why 
“he‟s the PI!” 
 I would like to thank my committee members who contributed significantly to this 
work.  Dr. Susan Craig simultaneously inspired me to pay close attention to the details of 
my experiments while also challenging me to synthesize my findings to understand the 
broader impacts of the work.  Dr. Cheng Zhu has instilled in me the importance of 
precision when communicating my scientific findings.  Dr. Evan Zamir was always 




candid opinions of this work.  Dr. Andrew Kowalczyk reinforced the need to be 
hypothesis-driven, especially when working with biological systems.  Dr. Hang Lu 
provided insightful critique of this work and taught me the importance of clarity when 
communicating scientific data. 
 Members of the Garcia lab, past and present, have been a tremendous source of 
support, laughter, and all around good times.  I thank Sean Coyer who introduced me to 
the lab and taught me the ways of the spinning disk.  It was a wild, hilarious, humbling, 
maddening, often-times ridiculous ride.  I can‟t think of a better person to have shared it 
with.  Thank you Sean, for never making me feel like I complained too much and for 
always having a great pep-talk ready whenever I needed it.  I thank Dr. Charlie Gersbach 
for turning a hard-core mechanical engineer into a true cloning master.  I‟m convinced 
that Charlie, through hard work and creativity, will become a world famous scientist.  A 
huge shout-out goes to Dr. Fantastic, aka Dr. Tim Petrie, who befriended me early on, 
despite his intense dislike for all things Midwest (read – not California).  Tim taught me, 
among other things, the importance of reading and following the directions on frozen 
pizza boxes, that we can never watch a sports game involving our favorite teams and 
expect victory, and that a career as a scientist is way better than any alternative.  Kellie 
Burns has been there every step of the way on this project.  She taught me how to pipette 
(I had never seen one when I started in the lab), transform bacteria, and prep plasmid 
DNA.  Although we both would like to forget it, Kellie and I are forever bound together 
by  FAK, talin siRNA, and countless Western blots and flow cytometry experiments.  She 
truly keeps the Garcia lab running and I can‟t thank her enough for all of her hard work 




when you combine raw talent, scientific curiosity, and hard work.  Thanks for not getting 
too mad at me when we fed that entire pizza to The General.  Ted T. Lee showed up late 
in my grad school career, yet made an immediate and lasting impact.  Ted taught me not 
to take myself too seriously and to enjoy the finer things in life.  Oh, I should also 
mention that, in addition to our extracurricular activities, Ted was integral in helping me 
complete the last phase of the project.  I also thank Dr. Nate Gallant for always answering 
the phone when I called, even though it meant digging into the details of the research 
project he completed many moons ago.  Asha Shekaran is my favorite Singaporean with 
whom I have shared many laughs over the years.  A word to the wise, never 
underestimate her considerable, almost superhuman skillz in research, billiards, shotgun 
shooting, fencing, and knowledge of American slang.  Her only known weakness is 
Yahoo! Pool.  My other desk mate, Dr. Jenn Phillips, deserves special credit for putting 
up with the Boy‟s Only Club consisting of Sean and me.  Jenn was always ready and 
willing to provide advice (scientific and otherwise) or share in a joke, despite the fact that 
I reeked of carbs.  Dr. Joe Charest is quite possibly the most talented, level-headed 
engineer I have ever encountered.  I walked away from every conversation I had with Joe 
a smarter and more humble person.  Abbey Wojtowicz and Amanda Walls Bridges are 
quite possibly the nicest and second nicest people I have ever met (no particular order).  
When I joined the lab, they quickly made me feel welcome, despite my inability to 
remember their names for the first year or so.  I‟d also like to thank the only adopted 
Garcia lab member in the history of the lab, Julia Henkels.  Julia taught me that life as a 
grad student isn‟t all that bad and that being busy with lab work is no excuse for 




have never heard him complain about anything.  And whether he knows it or not, Nduka 
has set an example of hard work to which I strive.  Thanks go to Rachel Whitmire who 
fought the good fight against the Lab‟s most powerful force – entropy.  She soothed the 
pain of early morning lab cleanups with amazing breakfast casseroles that would make 
Ron Swanson proud.  Speaking of great, free, lab food, Stacie Gutowski cannot be 
thanked enough for the many wonderful baked treats that provided much needed sugar 
during long days in the lab.  I thank Dr. Ankur Singh for his unsolicited support of my 
work and belief that I did, indeed, have more than enough data to graduate.  Dr. Ram 
Selvam provided a fine example of how to handle the stresses of academic life with ease.  
I‟m still not clear on the details, but I think his secret has something to do with his lunch 
of Spicy Cheetos, curry, and rice.   Thanks to Amy Chen, Apoorva Kalasuramath, Dr. 
Imen Hannachi, Dr. Susan Lehman, I leave knowing that the lab is in very capable hands. 
 Many people provided indispensible technical guidance and tools that directly 
contributed to the success of this thesis work.  Dr. Brock Wester is a clean room master.  
He gave of his time and expertise and fabricated several molds that myself and others in 
the Garcia Lab use on a daily basis.  Thanks Brock!  Special thanks go to Dr. Jan 
Scrimgeour who was an essential contributor to the FRAP work presented in this thesis.  
Jan tamed the beast that is the Nikon EZ-C1 FRAP module – an amazing feat of scientific 
prowess and Zen-like patience. Steve Woodard, and before him Johnafel Crowe, were 
instrumental in the development of the stable vinculin-eGFP expressing cell lines.  In 
addition to running the cell sorter, Steve was always available and willing to help with 
the project in any way that I needed.  Thank you, Steve, for never making me feel like I 




 My grad school experience was made whole by the strong friendships I developed 
with those who shared the journey.  Rich Carpenedo helped me push myself harder than I 
ever that was possible by way of ridiculous burrito eating challenges.  Crossfit was hard, 
too.  Brent Urhig deserves thanks for showing me what a real Halloween costume looks 
like and for providing a daily reminder of the importance of looking people in the eye 
when I talk to them.  Vince Fiore and I have become good friends, despite (or perhaps 
because of) our hometown allegiances.  Yes, Vince, the Bengals are garbage, but are 
they‟ll really any worse than the Pirates?    Chris Dosier is still dangerous, but he can be 
my wingman anytime.  I also want to thank those members of wing 2D, past and present, 
for making the Lair of Inefficiency the funniest, busiest, most entertaining places that I 
will ever work.    
 My time at Tech wouldn‟t have been the same without the IBB BBUGS 
intramural sports teams.  Tim Petrie, Bryan Bell, Brent Urhig, Andres Bratt-Leal, Rich 
Carpenedo, Sean Coyer, Ed Phelps, Jeremy Lim, Eric Ping, Jay Sy, Ken Dupont, Chris 
Edens and many others experienced many glorious victories against the likes of inferior 
grad departments including ChBE, ASDL, SSDL, and most importantly, the MBAs.  May 
we never forget that we almost won the school championship in flag football. 
Special thanks go to my BBUGS Industry Co-Chairs, Yash Kolambkar and Chris 
Lee.  Yash was instrumental in helping me see the importance of activities apart from my 
thesis work.  After Yash moved on, Chris Lee stepped in and immediately began making 
his own mark on the LIFE seminar series.   
I thank the members of the staff of IBB whose work often goes unnoticed but 




Meg McDevitt, Katherine Montgomery, Floyd Wood, Alyceson Andrews, James Godard, 
and Vivian Johnson deserve special thanks for helping me successfully complete this 
thesis. 
The completion of dissertation was due in no small part to the love and support I 
received from my wife, best friend, and fiercest supporter, Dr. Professor Kelly Erby.  Her 
hard work and dedication to….well….everything she does, inspired me throughout the 
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Cell adhesion to extracellular matrices (ECM) is essential to numerous 
physiological and pathological processes.  Cell adhesion is initiated by binding of the 
transmembrane integrin family of receptors to an ECM ligand such as fibronectin (FN).  
Once bound, integrins cluster together and form focal adhesions (FA).  FAs serve as 
structural links and signal transduction elements between the cell and its extracellular 
environment.  While a great deal of progress has been made in identifying the 
biochemical components that comprise focal adhesions and the roles they play in 
migration, cell spreading, and signaling, the contributions of these proteins to mechanical 
interactions between the cell and its environment remain poorly understood. 
 A FA adhesion protein of particular importance is vinculin.  When localized to 
focal adhesions, vinculin forms a ternary complex with talin and 1-integrin.  This 1-
integrin-talin-vinculin complex plays a central role in the regulation of FA assembly and 
cell spreading and migration.  Nevertheless, the specific contribution to adhesive force 
generation of the 1-integrin-talin-vinculin complex remains poorly understood. 
 The objective of this project was to analyze the role of vinculin in the cell 
adhesion strengthening process.  Our central hypothesis is that vinculin modulates 
adhesion strength via regulating the size and/or composition of the integrin-talin-vinculin 
complex.  We used a novel combination of biochemical reagents and engineering 
techniques along with quantitative and sensitive adhesion strength measurements to 
provide new insights into how the structure of vinculin contributes to cell adhesion 
strength.  








Cell adhesion to extracellular matrices (ECM) is essential to numerous 
physiological processes including cell migration, embryonic development, and proper 
inflammatory responses. Abnormalities in adhesion can lead to pathological conditions 
such as cancer metastasis and impaired wound-healing.  Cell adhesion is initiated by 
binding of the transmembrane integrin family of receptors to an ECM ligand such as 
fibronectin (FN).  Once bound, integrins cluster together and nascent focal complexes 
develop consisting of a coordinated mixture of signaling and scaffolding proteins.  These 
structures, under application of force generated by the internal contractile machinery, 
further develop into larger, more sophisticated structures termed focal adhesions (FA).  
FAs serve as structural links and signal transduction elements between the cell and its 
extracellular environment.  While a great deal of progress has been made in identifying 
the biochemical components that comprise focal adhesions and the roles they play in 
migration, cell spreading, and signaling, the contributions of these proteins to mechanical 
interactions between the cell and its environment remain poorly understood. 
 A FA adhesion protein of particular importance is vinculin, a ubiquitously 
expressed actin-binding protein that is found both at sites of cell-cell and cell-matrix 
junctions.  First identified in 1979, research during the past thirty years has vastly 
increased our understanding of the functional and biochemical roles of vinculin.  When 
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localized to focal adhesions, vinculin forms a ternary complex with talin and 1-integrin.  
This integrin-talin-vinculin complex plays a central role in the regulation of FA assembly 
and cell spreading and migration.  Nevertheless, the specific contribution to adhesive 
force generation of the integrin-talin-vinculin complex remains poorly understood. 
 The objective of this project is to analyze the role of vinculin in the cell adhesion 
strengthening process.  Our central hypothesis is that vinculin modulates adhesion 
strength via regulating the size and/or composition of the integrin-talin-vinculin complex.  
We base this hypothesis on previous work in our lab demonstrating that levels of bound 
integrin and focal adhesion assembly strongly modulate adhesion strength and recent 
evidence that suggests vinculin, talin, and integrin form a ternary complex that regulates 
the dynamics of focal adhesions. The rationale for this project is that use of a novel 
combination of biochemical reagents and engineering techniques along with quantitative 
and sensitive adhesion strength measurements will provide new insights into how the 
structure of vinculin contributes to cell adhesion strength.  Using these methods, we will 
address the objective of this project with the following specific aims: 
 
1: Examine role of vinculin in FAK-mediated steady-state adhesion strength   
 FAK, an essential non-receptor tyrosine kinase, plays pivotal roles in migratory 
responses, adhesive signaling, and mechanotransduction.  Previous work in our lab 
indicated that FAK regulates both short and long-term adhesive force generation in 
fibroblasts.  We demonstrated that FAK influences short-term adhesion strength by 
modulating integrin activation, however, it remained unclear how FAK modulated 
steady-state adhesion strength. 
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We hypothesized that FAK modulates long-term adhesion strength by controlling 
vinculin localization to sites of focal adhesions.  Using a combination of RNAi 
knockdown of vinculin, RNAi knockdown of FAK, various biochemical assays, and a 
spinning disk for measuring adhesive strength, we analyzed the contributions of vinculin 
in modulating force transmission across focal adhesions during FAK-mediated steady-
state adhesion strength. 
 
2: Examine the contributions of vinculin in actin-myosin contractility induced adhesion 
strength 
 Actin-myosin contractility modulates focal adhesion assembly and stress fiber 
formation.  These processes regulate cell behaviors including migration, neurite 
extension, cytokinesis, muscle cell contraction, cell cycle progression, angiogenesis, and 
differentiation.  To date, the contributions of actin-myosin contractility to adhesive 
interactions have been characterized by migration and spreading assays, leaving in a gap 
in knowledge regarding how cell-generated contractile forces and focal adhesion 
assembly regulate adhesion strength.   
 Our working hypothesis was that actin-myosin contractility would modulate 
adhesion strengthening by changing levels of matrix-bound integrins and assembly of 
focal adhesions.   Using a hydrodynamic adhesion assay in combination with chemical 
contractility inhibitors and various biochemical assays we analyzed the contributions of 
contractility to fibroblast adhesion strengthening.    
 
  4 
 
3: Examine the specific contributions of the head and tail domains of vinculin to cell 
adhesion strength 
 Steady-state adhesion strength measurements in the presence or absence of FAK 
demonstrated the FAK modulates adhesion strength by regulating vinculin localization to 
focal adhesions.  In addition, actin-myosin contractility modulates adhesion strength 
through assembly of vinculin-containing focal adhesions.  These results demonstrate the 
importance of vinculin in generating adhesive forces, however, the relative contribution 
of specific domains of the vinculin molecule, remain unclear. 
Our working hypothesis was that vinculin modulates adhesion strength by 
modulating the size, composition, and cytoskeleton connectivity of the integrin-talin-
vinculin complex. We engineered cells to express wild-type and various mutants of 
vinculin and used them in combination with a hydrodynamic adhesion assay and various 
biochemical techniques to understand the relative contributions of the head and tail 
domains of vinculin. 
4: Characterize the force-dependent dynamics of vinculin in focal adhesion 
 Focal adhesions (FAs) sense and respond to mechanical forces.  The molecular 
mechanism(s) involved in this process, however, have yet to be determined.  At sites of 
focal adhesions, vinculin adopts an open, active conformation and binds to talin and F-
actin.  The interaction between talin and vinculin has recently been proposed as a 
potential force-sensing unit.  In addition, it is now known that vinculin transfers force in 
focal adhesions and that the dynamic behavior of the protein is dependent on the spatial 
location in the cell.  To date, however, there exists no direct evidence that vinculin 
dynamics are modulated by the force applied to the focal adhesions.     
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 Our working hypothesis was that force transferred through focal adhesion 
increases the dynamic stability of the vinculin molecule in focal adhesions.  The rationale 
for this hypothesis is that as the force applied to a focal adhesion increases, so too does 
the force transferred across the vinculin molecule, making it less able to dissociate from 
its binding partners (talin and F-actin).  We developed a novel technique combining 
fluorescent recovery after photobleaching (FRAP) with traction force measuring devices 
to characterize how vinculin dynamics are modulated by force across focal adhesions. 
 
Project Significance 
Cell adhesion to the extracellular matrix is required for embryogenesis and the 
proper organization, maintenance, and repair of tissues as it allows for the development 
of mechanical forces and intracellular cues that regulate cell survival and migration 
(Danen and Sonnenberg, 2003; De Arcangelis and Georges-Labouesse, 2000). The 
absolute embryonic lethality of the deletion of a wide variety of adhesion related genes, 
including integrin receptors, extracellular matrix and focal adhesion components, 
indicates the necessity of cell adhesion in development (George, 1993; Stephens et al., 
1995; Xu et al., 1998a).  Abnormalities in adhesion are responsible for a wide-variety of 
pathological states including deficient immune response, blood clotting, and tumor 
metastasis (Wehrle-Haller and Imhof, 2003).  Integrin-mediated anchorage of cells to the 
ECM is a complex process that comprises integrin-ligand binding, clustering of bound 
receptors, and linkage to the contractile cytoskeleton of the cell (Critchley, 2000; Geiger 
et al., 2001).  Specifically, the linkage between integrins and the actin-cytoskeleton is 
mediated by FAs.  These supramolecular structures are composed of both structural 
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(talin, vinculin, -actinin) and signaling (FAK, paxillin) molecules and are critical 
regulators of both adhesion force generation and cell migration (Bershadsky et al., 2006). 
A FA component of particular importance is vinculin, a 116-kDa cytoskeleton-associated 
protein found in the majority of cell and tissue types. Vinculin plays an essential role in 
both development and proper cardiac function in mice studies (Xu et al., 1998a; Zemljic-
Harpf et al., 2007).  Cell culture experiments suggest that vinculin plays important roles 
in migration, adhesion, survival, and proper focal adhesion dynamics.  Importantly, 
vinculin has no known enzymatic activity and therefore must exert influence on adhesion 
processes by directly interacting with partner proteins.  While significant progress has 
been made in identifying how vinculin modulates its interactions with its numerous 
binding partners, little is known about how the protein contributes to the generation of 
adhesion forces.  As an outcome of the proposed investigations, we analyzed the specific 
contribution of vinculin to the generation of cell adhesive forces.  Furthermore, using our 
unique combination of reagents and measurement tools, we identified the importance of 
specific structural domains of the vinculin molecule to the generation of cell adhesion 
force.   
The proposed work is significant because it provides novel insights as to the 
relative influence of the head and tail domains of vinculin to the modulation of force 
transfer between the external matrix and the internal cytoskeleton.  These studies add an 
important dimension to our existing knowledge of the dynamics, regulation, and function 
of adhesion complexes.  In addition, the results of these experiments will provide a new 
context for understanding the role of vinculin in many physiologic and pathologic 
processes.   






Adhesion Force Generation 
Adhesion to ECM components such as FN and collagen, is primarily mediated by 
the integrin family of heterodimeric () receptors (Hynes, 2002).  Integrin-mediated 
adhesion is a highly coordinated process that is first initiated by activation and binding of 
the integrin to its ECM ligand (Choquet et al., 1997; Faull et al., 1993; Friedland et al., 
2009).  Once bound, integrins rapidly cluster together and generate linkages to the actin 
cytoskeleton  mediated by the supramolecular structures termed focal adhesions (FA) 
(Geiger et al., 2001).  Morphologically, FAs are elongated, streak-like  structures 
typically 3-10µm in length located near the periphery of the cell. There, they mediate 
strong adhesion to the ECM by modulating force transfer between integrins and the actin 
cytoskeleton.  In addition to their structural role, FAs serve as signaling platforms that 
control various functions including differentiation, proliferation, and apoptosis (Sastry 
and Burridge, 2000).  Importantly, FAs are not static, rigid structures.  Rather, they are 
highly dynamic units that assemble and disassemble in response to a wide variety of 
mechanical and chemical stimuli.  Initial formation of FA is stimulated by the small 
GTPase Rho-A, while full maturation of focal adhesions is driven by actin-myosin 
contractility by an unknown mechanism (Amano et al., 1997; Chrzanowska-Wodnicka 
and Burridge, 1996).   
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 The generally accepted model for adhesive force generation, proposed by McClay 
and Erickson, proposes a two-step process; namely initial ligand binding followed by 
rapid strengthening (Lotz et al., 1989).  The strengthening arises from (i) increases in 
cell-substrate contact area (spreading) (ii) receptor recruitment to anchoring sites 
(recruitment and clustering), and (iii) interactions with cytoskeletal elements that lead to 
enhanced force distribution among bound receptors (focal adhesion assembly).  This 
model has been validated in several independent experimental systems (Balaban et al., 
2001; Choquet et al., 1997; Hato et al., 1998; Maheshwari et al., 2000). 
 
Vinculin 
 Vinculin, a 116-kDa protein, was first identified in 1979 in cultured chicken 
gizzard smooth muscle cells as a protein that localized to sites of close contact to the 
substrate at the termini of microfilaments (Geiger et al., 1980).  It has since been the 
focus of various areas of scientific research with the overall goal to understand both its 
physiologic relevance and how its unique structure regulates its function (Bakolitsa et al., 
2004; Borgon et al., 2004; Cohen et al., 2006; Gingras et al., 2006; Izard et al., 2004; 
Izard and Vonrhein, 2004).   
 
Molecular structure  
 Vinculin consists of five domains, each of which is built from four-helix bundles.  
The first three four-helix bundles, domains 1-3 (D1-D3), interact and form the globular 
head of the protein.  The fourth and fifth domains of the protein are similar in structure to 
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D1 and D2, except that D5 is connected to D4 by a long, proline-rich strap.  D5 is 
designated as the tail of vinculin (Vt). 
  Importantly, Vt binds strongly (Kd <10
-9
) to the pincer-like pocket formed by Vh 
(Bakolitsa et al., 2004).  This high affinity interaction is the result of two specific 
interactions between Vt and D1 and Vt and D4 (Cohen et al., 2005).  When Vt is bound 
to Vh, the protein is in an inactive state, meaning that sites for many of its binding 
partners (talin, actin, etc.) are masked (Figure 1A).  Vinculin activation involves 
dissociation of the Vt and Vh domains, revealing its full spectrum of binding sites (Figure 
1B). There are two competing models that describe the activation process of vinculin.  
The first postulates that vinculin is activated through a combinatorial pathway in which 
the coincidence of talin and F-actin are required for vinculin activation (Chen et al., 2006; 
Cohen et al., 2006).  This model is attractive because recent evidence suggests that in the 
closed-conformation, there is an exposed binding site in Vt for F-actin, which may be 
involved in activation (Ziegler et al., 2006).  Alternatively, several studies using isolated 
fragments of vinculin and talin have suggested that a single ligand, such as talin, is 
capable of activating the vinculin molecule (Bois et al., 2006; Izard et al., 2004; Izard and 
Vonrhein, 2004).  Interpretation of the latter model is limited by the use of protein 
fragments as opposed to the former, which makes use of full-length vinculin and talin. 
  
Functional roles  
 Vinculin is found in numerous cells and tissues, but has the most interesting 
organization in skeletal and cardiac muscle costameres (Pardo et al., 1983a, b) and 
cardiac intercalated disks (Koteliansky et al., 1984).  Here, vinculin forms a 
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subsarcolemmal lattice of transmembrane connections termed costameres.  These 
functional units physically connect myofibrils to the muscle cell membrane and 
extracellular matrix (Craig and Pardo, 1983; Sparrow and Schöck, 2009).  Importantly, 
focal adhesions that form when cells are cultured on stiff, 2-D substrates, are structurally 
and compositionally analogous to costameres (Samarel, 2005), thus making the study of 
FA on 2-D surfaces an appropriate model system for our analysis.   
 Several model systems indicate that vinculin plays an important physiologic role 
in force transmission, most notably in cardiomyocytes.  Mice heterozygous for vinculin 
are predisposed to stress-induced cardiomyopathy (Zemljic-Harpf et al., 2004), while 
deletion of the vinculin gene in mice is embryonically lethal (Xu et al., 1998a).  Cardiac 
specific knockout of vinculin and the vinculin homolog meta-vinculin disrupts cellular 
junctions and causes sudden death or dilated cardiomyopathy (Zemljic-Harpf et al., 2007) 
while ischemic events in mice models lead to disorganization of vinculin (Steenbergen et 
al., 1987).  In humans, diseases that lead to cardiac stress have shown to involve 
irregularities in vinculin levels and localizations (Vasile et al., 2006).  These effects are 
consistent with the paralysis and disrupted muscle organization in nematodes following 
deletion of the vinculin gene (Barstead and Waterston, 1991).  Taking together, these 
studies indicate that vinculin plays an important role in force transfer.    
 Interestingly, cultured cells do not require vinculin for survival, proliferation, or 
even FA formation (Xu et al., 1998b).  Cells lacking vinculin are more motile presumably 
as a result of their documented faster FA turnover (Xu et al., 1998b).  Furthermore, 
vinculin-null cells exhibit altered stiffness (Alenghat et al., 2000; Mierke et al., 2008) and 
disruptions in Rac-mediated lamellipodia protrusion (Goldmann and Ingber, 2002), cell 
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shape, spreading (Coll et al., 1995; DeMali et al., 2002; Xu et al., 1998b), and apoptosis 
(Subauste et al., 2004).  Further evidence of the functional role of vinculin in cells comes 
from FRET experiments demonstrating that vinculin exists in an inactive state in the 
cytoplasmic pool, but becomes activated at sites of FAs (Chen et al., 2005).   
 Importantly, extensive research has identified the numerous potential binding 
partners of vinculin including talin (Burridge and Mangeat, 1984), -actinin (Belkin and 
Koteliansky, 1987; Kroemker et al., 1994), paxillin (Turner et al., 1990), VASP (Brindle 
et al., 1996), vinexin/ponsin (Kioka et al., 1999; Mandai et al., 1999), and F-actin 
(Jockusch and Isenberg, 1981; Johnson and Craig, 1995). However, it remains largely 
unclear how in vitro binding corresponds to in vivo interactions.  For example, it was 
recently shown that vinculin head domain recruits paxillin to FA independent of vinculin 
tail, despite the known binding site for paxillin being located on vinculin tail (Humphries 
et al., 2007).  Recent evidence suggests that the head domain of vinculin regulates 
integrin dynamics through a yet to be determined pathway while the tail domain is 
responsible for linking FAs to the actin cytoskeleton (Humphries et al., 2007).  It remains 
to be determined how the different domains of vinculin contribute to cell adhesion 
strength. 
 
Spinning Disk Assay for Adhesion Strength Measurements 
 The spinning disk device, developed by García et al (Garcia et al., 1997) has been 
successfully integrated into studies in our lab over the last decade to measure the 
adhesion strength of a population of cells (Gallant et al., 2005; Garcia et al., 1998; García 
et al., 1998; Michael et al., 2009).  The device applies a well-defined range of shear 
  12 
 
forces to adherent cells and provides a robust and sensitive measure of their adhesion 
strength.  Briefly, substrates containing cells seeded on islands of controlled size and 
spacing are mounted on the device and spun at constant speed in spinning buffer.  Fluid 
flow over the cells on the disk produces a detachment force that is proportional to the 




In this system, cells at the center of the disk are exposed to negligible detachment force, 
while cell detachment increases towards the outside of the disk as higher shear force is 
applied.  Thus, in a single sample, a linear range of detachment forces is applied to a 
population of cells (approximately 75,000 cells per 25mm disk).  Following spinning, 
cells are fixed, stained, and counted at sixty-one radial positions.  On average, 
approximately ~6000 cells are counted per sample.  The fraction of adherent cells ( ) is 
then calculated by dividing the number of cells at each radial position by the number of 
cells at the center of the disc, where negligible detachment force was applied.  The 
detachment profile (  vs. ) is then fit to the sigmoid: 
 

  0.8r  3      where    shear stress; r  radial position from center  








1 eb(  50)
 where f0  normalized asymtote; 
                                  b  slope at inflection point; 
                                   50  50% cell detachment
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We define  as the mean shear stress.  Mean shear stresses are determined in response 
to various testing conditions including various ECM substrates, cell type, adhesive area, 
and adhesive time points. 
 
Generation of Cell Adhesive Force:  Contributions of Adhesive Area, Integrin 
Binding, and Focal Adhesion Assembly 
 Previous work in our lab has examined the contributions of adhesive area, integrin 
binding, and FA assembly to the generation of cell adhesive forces.  Gallant and 
coworkers engineered micropatterned substrates to control cell-substrate adhesive area 
and eliminate the contributions of cell shape and spreading to adhesion strengthening.  
Microcontact printing of self-assembled monolayers of alkanethiols on gold was used to 
create FN-coated, cell adhesive domains within a non-fouling/non-adhesive background.  
Fibroblasts were cultured on substrates with adhesive areas varying from 2-20µm in 
diameter and for different lengths of time.  Adhesion strength analysis was performed 
using the spinning disc and the data was analyzed in the context of integrin binding and 
FA assembly (Gallant et al., 2005). 
 These studies allowed for the development of quantitative relationships between 
functional (adhesive strength generation) and biochemical (integrin binding, FA 
assembly) events.  The results revealed a strong correspondence between the biochemical 
and functional outputs, demonstrating that these processes are tightly coupled.  
 
Role of Focal Adhesion Kinase in Adhesion  

 50
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 Focal adhesion kinase (FAK) is a widely expressed non-receptor protein tyrosine 
kinase that plays essential roles in adhesive interactions by functioning as a scaffold for 
focal adhesion components, including Src, Cas, talin, and paxillin (Hanks et al., 1992; 
Polte and Hanks, 1995; Schaller et al., 1992; Schaller et al., 1999) and by providing 
signals that promote survival by blocking apoptotic pathways (Xu et al., 2000).  FAK is 
essential for many physiologic processes including development and organogenesis 
(Furuta et al., 1995).  Tissue specific knock-outs have revealed important roles for FAK 
in angiogenesis, branching tubulogenesis, innervations and mylenation, cardiac 
development, and blood-testis barrier function (Braren et al., 2006; Forrest et al., 2009; 
Peng et al., 2008; Shen et al., 2005; Siu et al., 2009; Watanabe et al., 2008; Wei et al., 
2009). 
 FAK modulates cell migration via focal adhesion turnover dynamics (Owen et al., 
1999; Wang et al., 2001; Webb et al., 2004).  FAK also plays a role in lamellipodia 
protrusion and actin cytoskeleton polymerization (Siesser et al., 2007).  Combined, it is 
clear that the contributions of FAK to cell motility and FA dynamics are well defined.  
However, there lacks a general understanding of how FAK contributes to the generation 
of adhesive forces.  We recently reported that FAK modulates short-term adhesion 
strength by promoting integrin activation (Michael et al., 2009).  This work also 
demonstrated that FAK modulates long-term adhesion strength and implicated vinculin as 
a key component of force modulation. 
 
Role of Actin-Myosin Contractility in Adhesion 
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 Contractile forces generated inside the cell regulate migration, neurite extension, 
cytokinesis, muscle cell contraction, cell cycle progression, angiogenesis and 
differentiation (Griffin et al., 2004; Mammoto et al., 2009; Mammoto et al., 2004; 
McBeath et al., 2004; Parizi et al., 2000; Polte et al., 2004; Tanaka and Sabry, 1995; 
Wozniak et al., 2003).  Contractility results from dynamic interactions between actin 
filaments and myosin, which are regulated via phosphorylation of myosin light chain 
(MLC) (Kaibuchi et al., 1999; Worthylake and Burridge, 2003).  Rho GTPases control 
the formation of stress fibers and focal adhesion assembly by modulating MLC 
phosphorylation and generating actin-myosin contractility (Amano et al., 1997; 
Chrzanowska-Wodnicka and Burridge, 1996; Totsukawa et al., 2000).  When activated 
by serum factors, such as lysophosphatidic acid (LPA), Rho acts through its effector Rho-
kinase (also termed ROCK), to enhance the contraction of smooth muscle cells as well as 
nonmuscle cells by either inactivation of myosin phosphatase (Kimura et al., 1996) or 
direct phosphorylation of MLC (Totsukawa et al., 2000).  Contractile forces can also be 
modulated by MLC kinase (MLCK), which promotes assembly of actin-myosin filaments 
and MLC phosphorylation (Gallagher et al., 1997). 
 The equilibrium of forces within a cell represents a balance of internal contractile 
forces and anchoring forces to the underlying substrate (Ingber, 2003; Zhu et al., 2000).  
This complex and dynamic balance is governed by the size and distribution of cell-
substrate adhesive structures, cytoskeletal architecture, and spatiotemporally-regulated 
internal contractile forces.  The contributions of actin-myosin contractility to adhesive 
interactions have been characterized primarily in spreading and migration assays.  While 
these functional measurements have identified key roles for actin-myosin contractility in 
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focal adhesion assembly, stress fiber formation, and migratory forces (Amano et al., 
1997; Chrzanowska-Wodnicka and Burridge, 1996; Worthylake and Burridge, 2003), 
relatively little is known about how actin-myosin contractility and focal adhesion 
assembly regulate cell adhesive forces.   
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CHAPTER 3 
FOCAL ADHESION KINASE-DEPENDENT REGULATION OF 





Focal adhesion kinase (FAK), an essential non-receptor tyrosine kinase, plays 
pivotal roles in migratory responses, adhesive signaling and mechanotransduction.   
FAK-dependent regulation of cell migration involves turnover dynamics as well as actin 
cytoskeleton polymerization and lamellipodia protrusion.  Whereas roles for FAK in 
migratory and mechanosensing responses have been established, the contribution of FAK 
to the generation of adhesive forces is not well understood.  Using FAK-null cells 
expressing wild-type and mutant FAK under an inducible tetracycline promoter, we 
analyzed the role of FAK in the generation of steady-state adhesive forces using 
micropatterned substrates and a hydrodynamic adhesion assay.  FAK expression reduced 
steady-state strength by 30% compared with FAK-null cells.  FAK expression reduced 
*Modified from  
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vinculin localization to focal adhesions by 35% independently of changes in integrin 
binding and localization of talin and paxillin.  RNAi knock-down of vinculin abrogated 
the FAK-dependent differences in adhesive force.  FAK-dependent changes in vinculin 
localization and adhesive forces were confirmed in human primary fibroblasts with FAK 
knocked down by RNAi.  We demonstrate that FAK reduces steady-state adhesion 
strength by modulating vinculin recruitment to focal adhesions.  These findings provide 
new insight into the role FAK plays in regulating the mechanical interactions between a 
cell and the extracellular matrix. 
Introduction 
Mechanical interactions between a cell and its environment regulate 
morphogenesis, tissue homeostasis and remodeling and pathogenesis (Benlimame et al., 
2005; Hynes, 2002; Kumar and Weaver, 2009; Wozniak and Chen, 2009).  Cell adhesion 
to ECMs  provides adhesive forces mediating migratory processes, tissue structure and 
organization, and mechanotransduction responses (Danen and Sonnenberg, 2003; Hynes, 
2002; Ingber, 2003).  Adhesion to ECM components such as fibronectin and laminin, is 
primarily mediated by the integrin family of heterodimeric αβ receptors (Hynes, 2002).  
After activation and ligand binding, integrins rapidly associate with the actin cytoskeleton 
and cluster together to form the transmembrane portion of focal adhesions, discrete 
supramolecular complexes that contain structural proteins, such as vinculin, talin, and α-
actinin, and signaling molecules, including FAK, Src, and paxillin (Geiger et al., 2001).  
Focal adhesions function as structural links, providing strong adhesive forces, and signal 
transduction platforms between the cell and its extracellular environment.  These 
adhesive complexes are highly dynamic structures that are actively remodeled during cell 
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migration (Gupton and Waterman-Storer, 2006; Ridley et al., 2003).  
Assembly/disassembly of focal adhesions is regulated by numerous pathways in response 
to external stimuli, including growth factors and mechanical force (Greenwood et al., 
1998; Ridley and Hall, 1992; Riveline et al., 2001).  Whereas the biochemical 
connections in adhesive interactions have been extensively characterized (Zaidel-Bar et 
al., 2007), the interplay between molecular composition and adhesive forces remains 
poorly understood. 
 FAK, a widely expressed non-receptor protein tyrosine kinase, plays central roles 
in adhesive interactions by functioning as a scaffold for focal adhesion components, 
including Src, Cas, talin, and paxillin (Hanks et al., 1992; Polte and Hanks, 1995; 
Schaller et al., 1992; Schaller et al., 1999; Xing et al., 1994).  FAK functions as an 
integrator of integrin-mediated signaling to regulate cell migration, survival, cell cycle 
progression and differentiation (Ilic et al., 1995; Owen et al., 1999; Zhao et al., 1998) 
(Quach et al., 2009; Renshaw et al., 1999; Sieg et al., 2000; Tomar et al., 2009; Webb et 
al., 2004).  FAK expression is essential to development and organogenesis.  Deletion of 
the FAK gene results in early embryonic lethality due to defects in cell migration (Furuta 
et al., 1995).  Tissue-specific knockout of FAK produces functional defects in 
angiogenesis/vasculogenesis, branching tubulogenesis, innervation and myelination, 
cardiac development, and blood/testis barrier function (Braren et al., 2006; Forrest et al., 
2009; Peng et al., 2008; Shen et al., 2005; Siu et al., 2009; Watanabe et al., 2008; Wei et 
al., 2009).  FAK has also been implicated in tumor invasion and metastasis (Chan et al., 
2009; Shibue and Weinberg, 2009).  Finally, FAK has emerged as an important 
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mechanotransducer (Clemente et al., 2007; Leucht et al., 2007; Pirone et al., 2006; 
Schober et al., 2007; Wang et al., 2001; Young et al., 2009). 
 FAK-dependent regulation of cell migration involves focal adhesion turnover 
dynamics (Owen et al., 1999; Wang et al., 2001; Webb et al., 2004).  In addition, FAK 
modulates actin cytoskeleton polymerization and lamellipodia protrusion (Serrels et al., 
2007).  Whereas roles for FAK in migratory and mechanosensing responses have been 
established, the contribution of FAK to the generation of adhesive forces is not well 
understood.  We recently demonstrated that FAK promotes integrin activation to enhance 
the generation of cell-ECM adhesive forces (Michael et al., 2009).  These FAK-
dependent enhancements in integrin activation and adhesive strengthening only occurred 
during the early stages of the adhesive process.  In the present study, we analyzed the 
steady-state adhesive interactions and demonstrate that FAK reduces steady-state 
adhesion strength by modulating vinculin recruitment to focal adhesions.  These findings 
establish a multifaceted role for FAK in the generation of cell-ECM forces. 
Materials and Methods 
Cells and reagents 
Tet-FAK cells were maintained as described previously (Owen et al., 1999).  
Primary human dermal fibroblasts were kindly provided by A.P. Kowalcyzk (Emory 
University).  The FAK siRNA construct has been described (Benlimame et al., 2005).  
Retrovirus packaging and transductions were performed as described previously (Byers et 
al., 2002).  Monoclonal antibodies against vinculin (clone V284; Millipore), talin (clone 
8d4; Sigma), paxillin (clone Z035; Zymed) and tensin (clone 5; BD Biosciences) were 
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used for immunostaining.  Antibodies against vinculin (clone V284; Millipore) and FAK 
(06-543 polyclonal; Millipore) were used for Western  
blotting. 
Micropatterned substrates 
Micropatterned substrates were generated by microcontact printing of self-
assembled monolayers of alkanethiols on gold (Gallant et al., 2005).  Arrays of CH3-
terminated alkanethiol [HS-(CH2)11-CH3; Sigma] circles were stamped on to Au-coated 
glass coverslips using a PDMS stamp (Slygard 184/186 Elastomer-kit).  The remaining 
exposed areas were functionalized with a tri(ethylene glycol)-terminated alkanethiol [HS-
(CH2)11-(CH2CH2O)3-OH; ProChimia Surfaces].  Patterned substrates were coated 
with  human plasma fibronectin (20ug/mL), blocked with 1% heat-denatured BSA.  This 
process results in an array of fibronectin-coated circular islands 5µm in diameter spaced 
75µm apart to promote single cell attachment to each island. 
Adhesion strength assay 
Adhesion strength was measured using our spinning disc system (Gallant et al., 
2005; Garcia et al., 1998).  Micropatterned substrates with adherent cells were spun in 
PBS+2mM dextrose for 5 minutes at constant speed.  The applied shear stress (τ) is given 
by the formula 
            
where r is the radial position from the center and ρ, µ, ω are the fluid density, viscocity, 
and rotational speed, respectively.  In some experiments, the spinning buffer was 
  22 
 
supplemented with 5% dextran to increase the fluid viscosity.  After spinning, cells were 
fixed in 3.7% formaldehyde, permeabilized in 1% Triton X-100, stained with ethidium 
homodimer-1 (Invitrogen) and counted at specific radial positions using a 10X objective 
lens in a Nikon TE300 microscope equipped with a Ludl motorized stage, Spot-RT 
camera and Image-Pro 6.3 analysis system.  A total of 61 fields (80-100) cells per field 
before spinning were analyzed and cell counts were normalized to the number of cells in 
the center of the disk.  The fraction of adherent cells (f) was then fitted to a sigmoid curve  
  
 
               
 
where τ50 is the shear stress for 50% detachement and b is the inflection slope.  τ50 
characterizes the mean adhesion strength for a population of cells. 
Focal adhesion assembly 
For staining of focal adhesion components, cells were permeabilized in 
cytoskeleton-stabilizing buffer (0.5% Triton X-100 + 50 mM NaCl + 150 mM sucrose + 
3 mM MgCl2 + 20 µg/ml aprotinin + 1 µg/ml leupeptin + 1 mM PMSF + 50 mM Tris, 
pH 6) for 10 min, fixed in 3.7% formaldehyde for 5 min, blocked in 5% fetal bovine 
serum, and  incubated with primary antibodies against focal adhesion components 
followed by AlexaFluor-labeled secondary antibodies (Invitrogen).  Images were 
captured using a Nikon 100X objective (1.3 NA) and Spot RT Camera/Software. Focal 
adhesion area fractions and intensities were quantified using calibrated image analysis 
software (ImagePro 6.3, Media Cybernetics). 
RNA knock-down of vinculin 
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siRNA pooled sequences encoding for mouse vinculin (M-060130-00-0010) and a 
non-targeting (D-0 01210-01) negative control were purchased from Dharmacon.  FAK-
inducible cells were transfected using a Nucleofector II (Amaxa).  For each sample, 2 
million cells were resuspended in 100 µl of nucleofector solution MEF 2 with 1000 nM 
siRNA and 2.5 µg of pMAX GFP plasmid and co-transfected using program T-20 (60% 
transfection efficiency).  Twenty-four hours after transfection, cells were FACS-sorted 
for GFP expression and cultured in appropriate tetracycline condition for 48 h.  The 
spinning disk assay, Western blot, and immunostaining were performed 72 h after initial 
transfection. 
Statistical analysis 
Non-linear regression analysis was performed using SigmaPlot 2001 software 
(SPSS).  Analysis of variance (ANOVA) statistical analyses were performed using 
SYSTAT 11 software.    
Results 
FAK reduces steady-state adhesion strength 
To examine the role of FAK in adhesive force responses, we used FAK-null cells 
engineered for tetracycline-regulated expression of wild-type and mutant FAK (Tet-FAK 
cells)(Owen et al., 1999).  In these cells, FAK is expressed to high levels in the absence 
of tetracycline, whereas FAK expression is repressed in the presence of tetracycline in the 
culture media.  In the present study, Tet-FAK cells were maintained in the off-condition 
(FAK-) and FAK expression was induced at 48 hours prior to any experiment to ensure 
steady-state FAK levels (FAK+).  We analyzed two independent clones with equivalent 
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results and present results for one clone (clone 46 for wild-type FAK).   
Western blot analyses demonstrated that FAK is expressed at high levels in the 
absence of tetracycline, while FAK expression is repressed in the presence of tetracycline 
(Fig. 3.1C).  This inducible behavior in response to tetracycline is specific for FAK as no 
differences in expression levels were detected between these two culture conditions for 
other proteins, including vinculin (Fig. 3.1C).  In addition, we further examined levels of 
the FAK family member Pyk2 for potential compensatory effects in the absence of FAK.  
It has been reported that loss of FAK expression results in upregulation of Pyk2 levels 
(Lim et al., 2008).  However, we did not observe differences in Pyk2 protein levels in 
response to inducible FAK expression in Tet-FAK cells (Fig. 3.1C).  Thus while Pyk2 
upregulation was associated with the establishment of FAK-/- cells and is maintained in 
Tet-FAK cells (Owen et al., 1999), any differences in the cell behavior resulting from 
induced FAK expression in the Tet-FAK cells cannot be attributed to further changes in 
Pyk2 expression.    
To analyze cell adhesive responses, Tet-FAK cells were cultured overnight on 
fibronectin-coated micropatterned substrates (5 µm diameter circles, 75 m center-to-
center spacing) to ensure equivalent adhesive area and cell shape between FAK+ and 
FAK- conditions.  Tet-FAK cells readily adhere and remain constrained to the 
micropatterned area as single cells, consistent with previous analyses with other cell 
types (Gallant et al., 2005).    
We measured the steady-state levels of adhesion strength for FAK+ and FAK- 
cells at 24 hours using a hydrodynamic adhesion assay that provides direct and sensitive 
population-based measurements of adhesive force (Gallant et al., 2005).  We previously 
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demonstrated that steady-state adhesion is reached by 4 hours in this cellular system 
(Michael et al., 2009).  For this adhesion assay, coverslips containing micropattered cells 
are placed and spun on a rotating disk submerged in buffer at prescribed speeds.  The 
disk rotation generates a well-defined 3-D fluid flow that applies a controlled 
hydrodynamic force to adherent cells.  The hydrodynamic force increases linearly with 
radial position along the surface of the coverslip, such that cells at the center of the 
substrate experience negligible forces whereas the applied detachment force increases 
toward the outer edge of the disk, resulting in decreasing cell numbers.  In this manner, a 
linear range of forces is applied to a large cell population and adhesive strength 
measurements are obtained for > 6,000 cells in a single experiment.  After spinning, 
adherent cells are fixed and stained, and cell numbers at different radial positions are 
quantified using a motorized microscope stage and image analysis system.  The fraction 
of adherent cells (f) is calculated by dividing the number of cells in each field by the 
number of cells at the center of the coverslip, where negligible forces are applied. The 
detachment profile is then fit to a sigmoid curve to obtain the shear stress for 50% 
detachment.  The shear stress for 50% detachment (50) represents the mean adhesive 
force.  Figure 3.1A shows typical detachment profiles (gray circles (FAK+) and squares 
(FAK-) represent cell densities at a specific radial position and fitted points (filled circles 
(FAK+), empty circles (FAK-)) and sigmoid fit.  The right-ward shift in the detachment 
profile for the FAK- cells compared to the FAK+ condition indicates a higher adhesive 
force.  The 50 values over several independent experiments were averaged (Fig. 3.1B).  
FAK- cells exhibited a 33% increase in adhesion strength compared to FAK+ cells (p < 
0.00005).  This finding indicates that FAK reduces steady-state adhesive forces. 
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Figure 3.1.  FAK modulates steady-state levels of adhesion forces.  (A)  Adhesive 
profiles showing the fraction of adherent cells as a function of applied shear stress for 
FAK-expressing (FAK+) and FAK-null (FAK-) cells.  Experimental values (FAK+, grey 
circles; FAK-, grey squares) were fitted to a sigmoid curve (fit values:  FAK+, filled 
circles; FAK-, empty circles) to obtain the shear stress for 50% detachment, indicated by 
vertical lines.  (B)  Mean adhesion strength values showing increased adhesive forces for 
FAK- cells (mean +/- S.D.).  1 dyne = 10
-5
N.  (C)  Tetracycline-regulated expression of 
FAK in FAK-null cells.  In the absence of tetracycline (-tet), FAK expression is 
activated.  Addition of tetracycline to the culture media (+tet) represses FAK expression.  
No differences in expression levels for Pyk2 or vinculin were observed between tet 
conditions.  Representative Western blots (top) and quantification of protein levels 
(normalized to FAK-null condition [+tet], bottom) are shown. 
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FAK modulates steady-state adhesive force via vinculin recruitment to the adhesive 
interface 
The reduction in steady-state adhesion strength for FAK-expressing cells could 
arise from (i) a decrease in the number of integrin/ECM bonds, (ii) modified 
position/distribution of bonds, (iii) reduction in the coupling of integrin/ECM bonds to 
the cytoskeleton (e.g., focal adhesion assembly), or (iv) change in the conformation state 
of the bound integrins.  We previously demonstrated that integrin α5β1 binding to 
fibronectin provided the dominant adhesion mechanism in this cellular system (Michael 
et al., 2009). Biochemical analyses of integrin binding revealed no differences in the 
numbers of bound integrin for FAK+ and FAK- cells at steady state, and no differences in 
integrin localization within the adhesive interface were observed by immunostaining 
(data not shown).  In addition, we previously demonstrated that there were no differences 
in the activation state of β1 between FAK+ and FAK- conditions at steady-state (Michael 
et al., 2009).  We therefore postulated that the differences in steady-state adhesive force 
arise from differences in focal adhesion assembly.  We have demonstrated that focal 
adhesion assembly, independently from integrin binding, contributes significantly to 
adhesion strength (Gallant et al., 2005).  Immunostaining for vinculin demonstrated 
localization of this cytoskeletal protein around the periphery of the micropatterned 
contact area for both FAK+ and FAK- cells (Fig. 3.2A).  We conducted a comprehensive 
analysis of vinculin localization focusing on fractional area, intensity (density), and the 
product of intensity and area (Fig. 3.2A).   FAK+ cells exhibited a significant (35%) 
reduction in the adhesive area occupied by vinculin compared to FAK- cells.  There are 
no differences in mean intensity between FAK+ and FAK- cells.  The differences in the 
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density & area product between FAK+ and FAK- are attributed to differences in focal 
adhesion area.  Differences in recruitment to the adhesive area were specific for vinculin 
as no differences in staining were detected between FAK+ and FAK- cells for talin, 
tensin, and paxillin (Fig. 3.2B,C). 
Recruitment of focal adhesion components to integrin clusters is expected to 
increase adhesive force by efficiently distributing mechanical loads among bound 
integrins.  In fact, we previously demonstrated that vinculin recruitment to focal 
adhesions enhances adhesion strengthening by 30% in fibroblasts (Gallant et al., 2005).  
We therefore carried out RNAi knock-down experiments to determine the contributions 
of vinculin to steady-state adhesion strength in FAK+ and FAK- cells.  Tet-FAK cells 
were co-transfected with a GFP plasmid and siRNA duplexes for either vinculin (VCL) 
or non-targeting control sequence (NT) via nucleofection.  After 24 h, cells were sorted 
for GFP expression and cultured in the appropriate tetracycline condition for 48 h prior to 
cell adhesion analyses.  siRNA VCL knock-down reduces vinculin levels by 80% in 
FAK+ and FAK- cells (Fig. 3.3A); the non-targeting control sequence has no effects on 
vinculin levels.  Immunostaining analyses demonstrated that vinculin knock-down 
eliminates the differences in vinculin localization between FAK+ and FAK- cells at 24 h 
(Fig. 3.3B), whereas significant differences in vinculin localization are still evident 
between FAK+ and FAK- cells for the non-targeting control siRNA.  Notably, vinculin 
knock-down abrogates differences in steady-state adhesion strength between FAK+ and 
FAK- cells (Fig. 3.3C).  Interestingly, no significant differences in vinculin recruitment 
or adhesion strength were observed between siRNA-treated and control FAK+ cells.  We 
attribute this finding to residual vinculin localization to focal adhesions since only 15-
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20% of the total vinculin pool localizes to focal adhesions (Gallant et al., 2005).  Vinculin 
exhibits a high affinity for localization to focal adhesions and other investigators have 
experienced difficulties in completely eliminating vinculin localization from focal 
adhesions via RNAi approaches (S.W. Craig, personal communication). Taken together, 
these results demonstrate that FAK regulates steady-state adhesive force by modulating 
vinculin localization to focal adhesions. 
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Figure 3.2.  FAK modulates vinculin localization to the adhesive interface.  (A)  
Immunostaining for vinculin recruitment to the micropatterned adhesive area, showing 
differences in the vinculin-containing focal adhesion area (scale bar, 2 µm).  
Quantification of vinculin-occupied adhesive area, intensity, and area-intensity product 
shown in the left, middle, and right panels, respectively.  (B)  Immunostaining (talin) and 
quantification of focal adhesions (FA) components recruited to micropatterned adhesive 
area, showing no difference between FAK+ and FAK- cells. 
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Figure 3.3.  FAK regulates steady-state adhesive forces by modulating vinculin 
localization to focal adhesions.  (A)  RNAi knock-down reduced vinculin levels by 80% 
in FAK+ and FAK-.  NT, non-targeting control.  (B)  Vinculin knock-down eliminated 
differences in steady-state vinculin recruitment to the adhesive area between FAK+ and 
FAK- cells.  (C)  Vinculin knock-down eliminated differences in steady-state adhesion 
strength between FAK+ and FAK- cells.  1 dyne  = 10
-5
N. 
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FAK knock-down in human dermal fibroblasts increases adhesive force and vinculin 
recruitment 
We next examined the effects of FAK expression on adhesion strength and 
vinculin recruitment in primary fibroblasts to rule out any artifacts associated with the 
Tet-FAK cells.  Human dermal fibroblasts were transduced with FAK siRNA-puromycin 
or control puromycin retrovirus, and puromycin-resistant cells were selected.  Fibroblasts 
transduced with FAK siRNA retrovirus exhibited a 95% reduction in FAK expression 
compared to control cells, whereas vinculin and Pyk2 levels remained unchanged (Fig. 
3.4A).   
Measurements of adhesion strength for micropatterned cells showed 35% higher 
levels for fibroblasts with knocked-down FAK expression compared to control cells (Fig. 
3.4B).  This relative increase in adhesion strength is in excellent agreement with the 
results for the Tet-FAK cells.  Furthermore, consistent with our observations for Tet-FAK 
cells, FAK knock-down enhances vinculin, but not talin, localization to the adhesive area 
(Fig. 3.4C).   
  33 
 
 
Figure 3.4.  FAK knock-down in human dermal fibroblasts modulates adhesive forces.  
(A)  FAK siRNA-puro retrovirus efficiently reduced FAK levels compared with control.  
No significant differences in Pyk2 or vinculin expression levels were detected.  (B)  
Knock-down of FAK increases cell adhesion strength.  (C)  FAK knock-down enhances 





We demonstrate that FAK reduces steady-state adhesive force via vinculin 
localization to focal adhesions.  Vinculin localization to the adhesive interface most 
likely modulates adhesive force by altering the local distribution of forces at the adhesive 
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interface (Gallant et al., 2005; Gallant and Garcia, 2007).  This work provides new 
insights into the role of FAK in the generation of adhesive forces involved in mechanical 
interactions between a cell and its environment.  We recently demonstrated that during 
the early stages of adhesion FAK enhances the adhesion strengthening rate by 
upregulating integrin activation to enhance integrin binding (Michael et al., 2009).  These 
FAK-dependent changes in integrin activation and binding and adhesive force generation 
were only observed in the early stages (<1-2 hour) of the adhesion process.  In the present 
study, we demonstrate that, as the adhesive process reaches steady-state, FAK has an 
opposite effect in adhesive forces by reducing adhesion strength.  This down-regulation 
in adhesive force arises from a separate mechanisms involving vinculin localization to 
focal adhesions. Once localized to focal adhesions, vinculin is proposed to be the primary 
functional link between focal adhesions and the actin cytoskeleton (Humphries et al, 
2007).  Taken together, these results indicate that FAK plays a multi-faceted, time-
dependent role in adhesive force generation.  These time-dependent, mechanism-distinct 
roles for FAK in adhesive force generation may be related to the biochemically distinct 
stages in cell adhesion to fibronectin recently established by Sheetz and colleagues 
(Zhang et al., 2008).  Whereas we demonstrate significant contributions for FAK in 
adhesive force generation, previous studies with deformable substrates did not reveal a 
role for FAK in the development of traction forces (Wang et al., 2001; Pirone et al., 
2006).  We attribute these seemly contradictory observations to fundamental differences 
among cellular forces. We propose that mechanical interactions between a cell and its 
environment involve diverse force components (e.g., traction/propulsive, contractile, 
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tensile, adhesive). Importantly, these factors are not equal and should therefore be 
considered as distinct entities that together comprise cellular forces.    
The mechanism by which FAK regulates the steady-state levels of vinculin 
localization to the adhesive area has recently been shown to be dependent on FAK-
mediated paxillin phosphorylation (Pasapera et al., 2010).  Specifically, myosin II 
activity enhances FAK-mediated phosphorylation of paxillin on tyrosines 31 and 118 and 
enhances vinculin recruitment to focal adhesions.  Importantly, phospho-memetic 
mutations of paxillin enhance vinculin recruitment in a myosin-II independent manner.  
That fact that, in our system, FAK-null cells increase adhesion strength by enhancing 
vinculin recruitment to focal adhesions at first seems contradictory to the Pasapera 
finding.  A closer examination of the Pasapera data reveals that FAK Y397 
phosphorylation is not solely responsible for paxillin phosphorylation, and thus, vinculin 
recruitment to focal adhesions (Pasapera et al., 2010).   Interestingly, in a separate study, 
fluorescence recovery after photobleaching experiments demonstrated that vinculin 
exchange dynamics within focal adhesions are directly coupled to phosphorylation of 
tyrosine 1065 ((Mohl et al., 2009)).  Specifically, phosphorylation of vinculin decreases 
as focal adhesions mature and stabilize.  We postulate that, in addition to phospho-
paxillin-enhanced recruitment, it is possible that FAK phosphorylation of vinculin 
modifies the dynamics of vinculin in focal adhesions.   
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CHAPTER 4 
CONTRACTILIY MODULATES CELL ADHESION STRENGTH 







Actin-myosin contractility modulates focal adhesion assembly, stress fiber 
formation, and cell migration. We analyzed the contributions of contractility to fibroblast 
adhesion strengthening using a hydrodynamic adhesion assay and micropatterned 
substrates to control cell shape and adhesive area.  Serum addition resulted in adhesion 
strengthening to levels 30% higher than serum-free cultures.  Inhibition of myosin light 
chain kinase or Rho-kinase blocked phosphorylation of myosin light chain to similar 
extents and eliminated the serum-induced enhancements in strengthening.  Blebbistatin-
induced inhibition of myosin II reduced serum-induced adhesion strength to similar 
levels as those obtained by blocking myosin light chain phosphorylation.  Reductions in 
adhesion strengthening by inhibitors of contractility correlated with loss of vinculin and 
talin from focal adhesions without changes in integrin binding.  In vinculin-null cells, 
*Modified from  




, Gallant ND, Michael KE, Radhakrishna H, García AJ.  
Contractility modulates cell adhesion strengthening through focal adhesion kinase and 
assembly of vinculin-containing focal adhesions.  J Cell Physiol. 2010.  
1
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inhibition of contractility did not alter adhesive force, whereas controls displayed a 20% 
reduction in adhesion strength, indicating that the effects of contractility on adhesive 
force are vinculin-dependent.  Furthermore, in FAK-null mouse embryonic fibroblasts 
engineered to express FAK, inhibitors of contractility reduced serum-induced adhesion 
strengthening as well as eliminated focal adhesion assembly.  In contrast, in the absence 
of FAK, these inhibitors did not alter adhesion strength or focal adhesion assembly.  
These results indicate that contractility modulates adhesion strengthening via FAK-
dependent, vinculin-containing focal adhesion assembly. 
Introduction 
Integrin-mediated cell adhesion to the extracellular matrix (ECM) plays central 
roles in various cellular processes including survival, cell cycle progression, and the 
expression of tissue-specific phenotypes (Danen and Sonnenberg, 2003; Hynes, 2002).  
Cell adhesion comprises the coordinated evolution of binding of integrin receptors to 
adhesive domains in ECM ligands, integrin clustering, interactions with the actin 
cytoskeleton, and focal adhesion assembly (Geiger et al., 2001; Sastry and Burridge, 
2000).  Focal adhesions are discrete adhesive plaques that contain numerous structural 
(e.g., vinculin, talin, and -actinin) and signaling elements (e.g., FAK, Src, paxillin, and 
p130CAS).  Focal adhesions have emerged as putative mechanosensors for extracellular 
stimuli (Riveline et al., 2001; Wang et al., 2001).  For example, external forces exerted 
on integrins enhance focal adhesion assembly and increase the strength and rigidity of the 
linkage between integrins and the actin cytoskeleton (Choquet et al., 1997; Geiger et al., 
2009; Riveline et al., 2001; Wang et al., 1993).  Moreover, focal adhesion assembly plays 
a key role in the generation of strong traction forces.  Following initial integrin binding, 
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recruitment of focal adhesion components, such as vinculin and talin, result in graded 
increases in traction forces (Balaban et al., 2001; Galbraith et al., 2002; Tan et al., 2003).  
Focal adhesion assembly also contributes to cell adhesion strengthening by distributing 
bond forces along the cell-substrate interface (Gallant et al., 2005; Lotz et al., 1989).  
Nevertheless, the specific contributions of focal adhesion size and distribution to 
adhesion strength, independently from integrin-ligand bond strength and cytoskeletal 
architecture, remain poorly understood. 
 Contractile forces generated inside the cell regulate migration, neurite extension, 
cytokinesis, muscle cell contraction, cell cycle progression, angiogenesis and 
differentiation (Griffin et al., 2004; Mammoto et al., 2009; Mammoto et al., 2004; 
McBeath et al., 2004; Parizi et al., 2000; Polte et al., 2004; Tanaka and Sabry, 1995; 
Wozniak et al., 2003).  Contractility results from dynamic interactions between actin 
filaments and myosin, which are regulated via phosphorylation of myosin light chain 
(MLC) (Kaibuchi et al., 1999; Worthylake and Burridge, 2003).  Rho GTPases control 
the formation of stress fibers and focal adhesion assembly by modulating MLC 
phosphorylation and generating actin-myosin contractility (Amano et al., 1997; 
Chrzanowska-Wodnicka and Burridge, 1996; Totsukawa et al., 2000).  When activated 
by serum factors, such as lysophosphatidic acid (LPA), Rho acts through its effector Rho-
kinase (also termed ROCK), to enhance the contraction of smooth muscle cells as well as 
nonmuscle cells by either inactivation of myosin phosphatase (Kimura et al., 1996) or 
direct phosphorylation of MLC (Totsukawa et al., 2000).  Contractile forces can also be 
modulated by MLC kinase (MLCK), which promotes assembly of actin-myosin filaments 
and MLC phosphorylation (Gallagher et al., 1997). 
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 The equilibrium of forces within a cell represents a balance of internal contractile 
forces and anchoring forces to the underlying substrate (Ingber, 2003; Zhu et al., 2000).  
This complex and dynamic balance is governed by the size and distribution of cell-
substrate adhesive structures, cytoskeletal architecture, and spatiotemporally-regulated 
internal contractile forces.  The contributions of actin-myosin contractility to adhesive 
interactions have been characterized primarily in spreading and migration assays.  While 
these functional measurements have identified key roles for actin-myosin contractility in 
focal adhesion assembly, stress fiber formation, and migratory forces (Amano et al., 
1997; Chrzanowska-Wodnicka and Burridge, 1996; Worthylake and Burridge, 2003), 
relatively little is known about how actin-myosin contractility and focal adhesion 
assembly regulate cell adhesive forces.  This lack of quantitative understanding of 
adhesion strengthening limits the interpretation of functional studies of structural and 
signaling focal adhesion components.  Cell spreading and migration assays do not 
provide direct measurements of adhesion strength and generally serve as implicit 
indicators of adhesion strength due to the complex spatiotemporal relationships between 
migration/spreading and adhesion strength.  For instance, cell migration speed exhibits a 
biphasic dependence on adhesion strength (Palecek et al., 1997).  In the present study, we 
used a robust quantitative cell adhesion assay in combination with micropatterned 
substrates to control adhesive area in order to examine the role of actin-myosin 
contractility in cell adhesion strengthening. 
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Materials and Methods 
Reagents  
Human plasma fibronectin and Dulbecco‟s phosphate buffered saline (PBS) were 
obtained from Invitrogen (Carlsbad, CA).  Bovine serum albumin, mouse anti-talin and 
anti-biotin antibodies, and H-7 were purchased from Sigma (St. Louis, MO).  Mouse 
antibody against glyceraldehyde-3-phosphate dehydrogenase (GAPDH), rabbit anti-
paxillin, and rabbit anti-5 antibodies were obtained from Chemicon (Temecula, CA).  
Biotin-conjugated donkey anti-rabbit and donkey anti-mouse antibodies were obtained 
from Jackson ImmunoResearch (West Grove, PA).  Rabbit anti-FAK and mouse anti-
vinculin antibodies were purchased from Upstate Biotechnology (Lake Placid, NY).  
Rabbit anti-myosin light chain (MLC) 2 (Santa Cruz Biotechnology, Santa Cruz, CA) and 
rabbit anti-phospho-MLC (Abcam, Cambridge, MA) antibodies were also used.  Hoechst 
33258, AlexaFluor 488-conjugated antibody against mouse IgG, ethidium homodimer, 
and rhodamine phalloidin were purchased from Molecular Probes (Eugene, OR).  
Poly(dimethylsiloxane) (PDMS) elastomers and curing agents were obtained from Dow 
Corning (Midland, MI).  Inhibitors (Y-27632, HA-1077, blebbistatin, and cytochalasin D 
(CD)) were purchased from Calbiochem (La Jolla, CA). 3,3´-
Dithiobis(sulfosuccinimidylpropionate) (DTSSP) was purchased from Pierce Chemical 
(Rockford, IL).  Tri(ethylene glycol)-terminated alkanethiol (HO(CH2CH2O)3-
(CH2)11SH) was purchased from ProChimia Surfaces (Sopot, Poland).  All other reagents 
including hexadecanethiol (H3C(CH2)15SH) were purchased from Sigma. 
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Micropatterned Substrates 
Micropatterned arrays of adhesive islands within a non-adhesive background were 
prepared by microcontact printing of self-assembled monolayers of alkanethiols on gold-
coated glass coverslips .  A master template featuring circular holes (10 m diameter) 
with a 75 m center-to-center spacing was prepared on a Si wafer.  UV light was exposed 
to a photoresist-coated Si wafer through an optical mask (Gallant and Garcia, 2007a)with 
the desired pattern.  The UB-exposed area was then etched away, leaving a template mold 
of recessed wells of the pattern.  The template was coated with (tridecafluoro-1,1,2,2,-
tetrahydrooctyl1)-1-trichlorosilane under vacuum for 30 minutes to facilitate removal of 
the template from a PDMS stamp following the curing process.  PDMS precursors 
(Slygard 186:184, 10:1) and curing agents were vigorously mixed at 10:1 ratio, poured 
over the template in a 100 mm diameter glass Petri dish, placed under vacuum for 30 
minutes to remove air bubbles, and cured overnight at 65C.  Following curing, the 
PDMS stamp was peeled from the master template and sonicated in 70% ethanol for 30 
minutes.  Glass coverslips were cleaned in O2 plasma using a plasma etcher (Plasmatic 
Systems, North Brunswick, NJ) for 4 min and coated with Ti (100 Å) followed by Au 
(150 Å) using an electron beam evaporator (Thermonics, San Leandro, CA).  For 
stamping, the PDMS stamp was sonicated in 70% ethanol for 15 minutes, dried, and 
placed onto a glass slide for rigid backing.  The Au-coated glass coverslip was cleaned 
under a stream of N2 and laid down on a glass slide.  The patterned face of the PDMS 
stamp was brushed with 1.0 mM hexadecanethiol (in absolute ethanol) using a cotton 
swab, blown dry under a stream of N2 and overlaid onto the Au-coated glass coverslip for 
20 seconds.  Conformal contact of the stamp with the Au substrate generated CH3-
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terminated circular patterns on the glass coverslip that readily allow protein adsorption 
and cell adhesion.  The coverslip featuring hexadecanethiol islands was subsequently 
incubated in 1.0 mM ethanolic solution of (HO(CH2CH2O)3-(CH2)11SH) for 4 hours to 
create non-fouling domains around the cell-adhesive islands.  The micropatterned 
substrate was then rinsed twice with 70% ethanol and PBS, coated with fibronectin (20 
g/mL) for 30 minutes, then blocked with heat-inactivated serum albumin (1% w/v) for 
30 minutes, and incubated in PBS overnight to elute non-specifically adsorbed 
fibronectin from non-adhesive regions (Capadona et al., 2003).   
Cell Culture and Inhibitor Treatment  
Murine NIH3T3 fibroblasts (CRL-1658) were purchased from the American Type 
Culture Collection (Manassas, VA) and cultured in DMEM containing 10% newborn calf 
serum, penicillin (100 unit/mL), and streptomycin (100 g/mL).  Vinculin-null and 
vinculin +/+ mouse embryo fibroblasts were a kind gift from Eileen Adamson and have 
been previously described (Xu et al., 1998a).  Vinculin-/- and vinculin+/+ mouse embryo 
fibroblasts were cultured in DMEM supplemented with 10% FBS, sodium pyruvate (1 
mM), penicillin (100 units/mL), streptomycin (100 g/mL), and non-essential amino 
acids (1 mM).  Tet-FAK fibroblasts were engineered to express FAK under a 
tetracycline-regulated promoter have been previously described (Owen et al., 1999).  In 
the presence of tetracycline, FAK expression is repressed, whereas in the absence of 
tetracycline, high FAK levels are induced.  Tet-FAK cells were cultured in DMEM 
supplemented with 10% FBS, sodium pyruvate (1 mM), penicillin (100 unit/mL), 
streptomycin (100 g/mL), amphotericin B (0.25 g/mL), and non-essential amino acids 
(1mM) in the absence or presence of tetracycline (1.0 g/mL) for two days prior to cell 
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seeding.  Cells were enzymatically lifted from the culture dish using trypsin/EDTA and 
seeded onto micropatterned substrates at 225 cells/mm
2
.  Cell cultures were maintained 
for 16 hours in serum-containing media prior to analysis of steady state adhesion (Gallant 
et al., 2002).  For pharmacological treatments, cultures were incubated for 30 minutes 
prior to analysis in Y-27632 (50 M), H-7 (500 M), HA-1077 (50 M), blebbistatin 
(250 M), and CD (1 M).  For serum-free studies, cells were cultured in DMEM 
supplemented with 1% serum albumin and 0.1% ITS. 
Adhesion Assay 
Adhesion strength was measured using our spinning disc system.  Micropatterned 
substrates with adherent cells were spun in PBS+2mM dextrose for 5 minutes at constant 
speed.  The applied shear stress (τ) is given by the formula 
            
where r is the radial position from the center and ρ, µ, ω are the fluid density, viscocity, 
and rotational speed, respectively.  In some experiments, the spinning buffer was 
supplemented with 5% dextran to increase the fluid viscosity.  After spinning, cells were 
fixed in 3.7% formaldehyde, permeabilized in 1% Triton X-100, stained with ethidium 
homodimer-1 (Invitrogen) and counted at specific radial positions using a 10X objective 
lens in a Nikon TE300 microscope equipped with a Ludl motorized stage, Spot-RT 
camera and Image-Pro 6.3 analysis system.  A total of 61 fields (80-100) cells per field 
before spinning were analyzed and cell counts were normalized to the number of cells in 
the center of the disk.  The fraction of adherent cells (f) was then fitted to a sigmoid curve  
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where τ50 is the shear stress for 50% detachement and b is the inflection slope.  τ50 
characterizes the mean adhesion strength for a population of cells. 
Protein Expression and Phosphorylation  Levels 
Cultures were rinsed in PBS and lysed for 20 min at room temperature in RIPA 
buffer (150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 150 mM Tris, pH 
7.2) containing Na3VO4 (0.04% w/v) and protease inhibitors (10 g/mL leupetin, 10 
g/mL aprotinin, and 350 g/mL PMSF).  The protein content of total cell lysates was 
determined by microBCA assay (Pierce, Rockford, IL).  Identical amounts of cell lysates 
were mixed in sample buffer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 10% 
glycerol, and 0.1% bromophenol blue) and separated by SDS-PAGE (8% or 16% gels).  
After transferring to nitrocellulose membranes, proteins were visualized by incubating in 
primary and secondary antibodies and ECF substrate (Pierce, Rockford, IL).  Relative 
amounts of proteins were quantified by image analysis. 
Focal Adhesion Assembly 
For immunostaining of focal adhesion proteins, adherent cells were rinsed with 
PBS, fixed in ice-cold formaldehyde (3.7% in PBS) for 3 min, permeablized for 15 
minutes in cold 0.5% Triton X-100 containing protease inhibitors ( 20 g/mL aprotinin, 1 
g/mL leupeptin, and 350 g/mL PMSF).  After incubating in blocking buffer (5% FBS, 
0.1% Tween 20, 0.02% NaN3 in PBS) for 1 h at 37C, samples were incubated in primary 
antibodies for 1 h at 37C, followed by AlexaFluor488-conjugated secondary antibody, 
rhodamine phalloidin, and Hoechst 33258 for 1 h at 37C.  For quantification of proteins 
localized to focal adhesions, micropatterned cells were analyzed by a modified wet 
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 free) containing protease inhibitors.  A dry nitrocellulose sheet (PROTRAN 
BA85, Schleicher & Schuell) was then overlaid onto the cells for 1 min and rapidly 
removed to isolate cell bodies from basal cell membranes containing focal adhesions.  
Remaining adhesive structures on surfaces were scraped into sample buffer (100 L).  
Western blotting was used for quantitative analysis of recovered focal adhesion proteins. 
Integrin Binding  
Integrin binding was quantified via a cross-linking/extraction/reversal procedure 
(Garcia et al., 1999; Keselowsky and Garcia, 2005).  After rinsing cultures three times 
with PBS, DTSSP (1.0 mM in cold PBS + 2 mM dextrose) was incubated for 30 minutes 
to cross-link integrins to their bound ligands.  The cross-linking reaction was quenched 
by addition of Tris (50 mM in PBS) for 15 minutes.  Uncross-linked cellular components 
were then extracted in 0.1% SDS containing 10 g/mL leupeptin, 10 g/mL aprotinin 
and 350 g/mL PMSF.  Cross-linked integrins to their bound ligands were visualized by 
immunostaining with 5 integrin-specific antibodies.  Alternatively, bound integrins were 
quantified by Western blotting following cleaving of the cross-linker in 50 mM DTT and 
0.1% SDS for 30 minutes at 37C. 
Statistics  
Data are reported as mean  standard deviation.  ANOVA was used with a 95% 
confidence interval (SYSTAT 8.0, SPSS, Chicago, IL).  If ANOVA detected significant 
differences, Tukey HSD multiple comparison tests were performed to establish treatment 
effects. 
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Results 
Acto-myosin contractility regulates adhesion strength 
Cells were plated on fibronectin-coated micropatterned substrates with 
dimensions smaller than a cell diameter in order to control adhesive area and cell shape.  
This approach allows isolation of focal adhesion assembly from changes in cell 
spreading/shape and provides for direct comparisons among experimental groups.  We 
previously reported that NIH3T3 fibroblasts remained viable for several days when 
adhering to micropatterned circular islands with dimensions ranging from 2 to 20 m 
diameter (Gallant et al., 2005).  Cells maintained a round morphology (Fig. 4.1A), and 
their contact area and focal adhesions were constrained to the micropatterned domain. 
The 75 m center-to-center spacing of islands restricted a single cell to occupy one 
adhesive island, preventing interactions with neighboring cells.  To further validate our 
cell patterning system, we compared the adhesion strength of unpatterned, spread cells 
with those constrained to 10µm adhesive islands in the presence or absence of serum and 
LPA (Fig. 4.2A).  No significant differences were detected between the patterned and 
unpatterned cells and their respective treatment groups.   
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Figure 4.1.  (A) Phase contrast image of adherent NIH 3T3 cells cultured for 16 h on 
micropatterned substrate (scale bar: 10µm).  (B) Characteristic detachment profiles 
showing the fraction of adherent cells (f) versus applied shear stress (τ). The shear stress 
for 50% detachment (indicated by arrows in the profile), τt50, represents the mean 
adhesion strength. Adhesion strength is 632dyne/cm
2
 for untreated control cells, and is 
shifted left-ward to 451dyne/cm
2
 for cell treated with Y-27632 (50µM). 
 
 We measured adhesion strength using a spinning disk device that applies a range 
of well-defined hydrodynamic shear forces to adherent cells (Garcia et al., 1998).  For a 
particular sample, the fraction of adherent cells (f) is plotted as a function of the applied 
shear stress ().  From this detachment profile, the shear stress for 50% detachment (50), 
which represents the mean cell adhesion strength, is determined.  Fig. 4.1B depicts 
typical detachment profiles showing the fraction of adherent cells vs. applied shear stress.  
We chose a 16 hour culture time point for analysis of long-term adhesion strength 
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because it was previously demonstrated that the adhesion strength of NIH3T3 fibroblasts 
on micropatterned substrates reached constant values by 4 h and remained constant for up 
to 16 hours (Gallant et al., 2005).  Equivalent levels of adhesion strength were observed 
in serum- and LPA-treated cultures (640  55 dyne/cm
2
) (Fig. 4.2A).  These values are 




 Because actin-myosin contractility is driven by phosphorylation of MLC, which is 
regulated by MLCK and Rho-kinase (Gallagher et al., 1997), we used pharmacological 
inhibitors that impair phosphorylation of MLC to examine the contributions of 
contractility to adhesion strength.  Y-27632 is a specific inhibitor of Rho-kinase 
(Narumiya et al., 2000).  H-7 inhibits phosphorylation of MLCK, which in turn potently 
blocks phosphorylation of MLC (Volberg et al., 1994).  HA-1077 has a broad negative 
influence on both Rho-kinase and MLCK activity (Yanase et al., 2003).  Inhibitor dosage 
and exposure time were selected from published reports and preliminary experiments 
showing no gross adverse effects.  To examine the contributions of actin-myosin 
contractility inhibitors to cell adhesion strengthening, we measured adhesion strength of 
cells exposed to contractility inhibitors for 30 minutes prior to spinning.  In general, 
inhibitors of Rho-kinase and MLCK significantly reduced adhesion strength for cells 
adhering in the presence of serum as demonstrated by a left-ward shift in the detachment 
profile (Fig. 4.1B).  Adhesion strength values for each inhibitor (409  845 dyne/cm
2
 for 
Y-27632, 468  80 dyne/cm
2
 for H-7, and 473  84 dyne/cm
2
 for HA-1077) were 30-
35% lower than those for untreated controls in the presence of serum (640  55 
dyne/cm
2
) (Fig. 4.2B).  Although Y-27632 and HA-1077 are known inhibitors of Rho-
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kinase and actin-myosin contractility, Rho-kinase has other targets and, therefore, may 
alter cell-matrix adhesion by a mechanism not directly related to contractility (Amano et 
al., 2000).  As an alternative to inhibiting MLC phosphorylation, additional experiments 
were performed in the presence of blebbistatin, a specific inhibitor of myosin II activity 
that acts via a distinct mechanism (Kovács et al., 2004).  Blebbistatin also reduced serum-
induced cell adhesion strength to similar levels (480  110 dyne/cm
2
) as the agents that 
reduce MLC phosphorylation via inhibition of Rho-kinase and MLCK (Fig. 4.2B).  
Additional experiments under serum-free conditions revealed that these contractility 
inhibitors do not reduce adhesion strength below levels for untreated, serum-free samples 
(Fig. 4.2B).  Taken together, these results show that actin-myosin contractility accounts 
for the increases in adhesion strength resulting from serum stimulation.  Finally, 
treatment with cytochalasin D (CD) was included for comparison as CD is expected to 
modulate adhesion strength via a different mechanism, namely disruption of actin 
filament polymerization.  Cells treated with CD exhibited significantly lower adhesion 
strength (270  36 dyne/cm
2
) than cells treated with any of the contractility inhibitors or 
cells cultured under serum-free conditions. 
 Following treatment with these inhibitors, phosphorylation of MLC was analyzed 
by Western blotting.  For equivalent total MLC levels, relative amounts of 
phosphorylated MLC in cells treated with inhibitors were significantly decreased 
compared to untreated controls (Fig. 4.2C).  There were no differences in MLC 
phosphorylation levels among inhibitor treatments as determined by quantification of the 
Western blots in Figure 4.2C .  These results confirm essential roles of MLCK and Rho-
kinase in MLC phosphorylation.  In addition, since all inhibitor treatments reduced MLC 
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phosphorylation to the same level despite distinct mechanisms of action in blocking 
actin-myosin contractility, this result suggests that cell adhesion strength is regulated by 
overall levels of phosphorylated MLC rather than specific effects of Rho-kinase or 
MLCK. 
 To elucidate the mechanism by which cell detachment occurred on 10µm islands 
of fibronectin under the applied forces, cells were spun and stained for vinculin, F-actin, 
and DNA.  For control untreated samples, cells at the center of the disk, which experience 
low detachment forces, stained positive for vinculin and F-actin (not shown) in a manner 
similar to unstressed cells.  However, at the periphery of the substrate where detachment 
forces are highest, minimal traces of vinculin (Fig. 4.2D) and F-actin were observed.  
This negative staining indicates that cell detachment took place at the junction between 
focal adhesions and the underlying substrate, resulting in removal of the entire cell 
without gross failure.  Similar staining patterns were observed for cells treated with 
contractility inhibitors (Fig. 4.2D).  In contrast, cultures treated with CD displayed 
significant cytoskeletal debris and vinculin at the periphery of the sample following 
detachment (Fig. 4.2D).  This residual cytoskeletal debris indicates gross cell failure at 
points above focal adhesions due to loss of cellular integrity arising form impaired actin 
polymerization.  Taken together, these results indicate that inhibition of MLC 
phosphorylation and contractility does not reduce adhesion strength by compromising 
cellular integrity and that cell detachment under these conditions occurs at the focal 
adhesion-substrate interface. 
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Figure 4.2:  Adhesion strength for patterned and spread (unpatterned) NIH 3T3 
fibroblasts cultured under serum-containing or serum-free conditions, and treated with 
LPA and serum supplemented with Y-27632 (50µM) for 30min. Adherent cells were 
spun and analyzed to determine adhesion strength. *P < 0.04 relative to serum containing 
controls (mean ± standard deviation, n=3–5).  (B) Adhesion strength for micropatterned 
NIH 3T3 fibroblasts cultured under serum-containing or serum-free conditions, and 
treated with pharmacological agents for 30min: Y-27632 (50µM), H-7 (500µM),  HA-
1077 (50µM), blebbistatin  (250µM), or CD (1µM). Adherent cells were spun and 
analyzed to determine cell adhesion strength. *P < 0.05 and #P < 0.01 relative to no 
treatment controls (mean±standard deviation, n=3–5).  Dashed line represents adhesion 
strength for cells cultured under serum-free conditions.  (C)  Western blotting (left) for  
MLC and phosphorylated-MLC in cells cultured in serum-containing media on 
micropatterned substrates for 16 h and treated with Y-27632 (50µM), H-7 (500µM), and 
HA-1077 (50µM) for 30min and quantification (right) of protein levels (n=3).  (D)  
Immunostaining for vinculin on adherent cells on micropatterned islands (10mm 
diameter) of fibronectin located on the periphery of the disk following application of 
detachment forces. Cells on edge of disk are exposed to maximal detachment force. 
Cells treated with vehicle, Y-27632 (50µM), or CD (1µM) (scale bar: 10µm). 
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Reduction in cell adhesion strength correlates with dissolution of focal adhesions 
independently of changes in integrin binding 
 The reduction in adhesion strength as a result of inhibiting MLC phosphorylation 
is consistent with the role of MLC-mediated contractility in focal adhesion assembly and 
stress fiber formation.  Two mechanisms have been proposed for the regulation of focal 
adhesion assembly by contractility (Balaban et al., 2001).  Tension generated by actin-
myosin contractility on adhesion sites may regulate recruitment and assembly of focal 
adhesion components.  Alternatively, contractile forces may trigger changes in integrin 
binding affinity or bond density within the focal complex.  To explore these two 
possibilities, we first determined whether actin-myosin contractility modulates integrin 
binding to ECM.  We have previously shown that NIH3T3 adhesion to these 
micropatterned FN islands is mediated by integrin 51 (Gallant et al., 2005). 
Immunofluorescence staining confirmed that bound 51 integrins were present 
throughout the contact area with a preferential localization to the periphery of the 
adhesive area (Fig. 4.3A).  Equivalent staining patterns were observed between control 
and cells treated with contractility inhibitors, suggesting no differences in integrin 
intensity or distribution.  To confirm these observations, bound integrins were quantified 
using a biochemical cross-linking/extraction method that isolates integrins bound to 
fibronectin (Garcia et al., 1999; Keselowsky and Garcia, 2005).  Following recovery of 
bound integrins by cleaving the cross-linker and analysis by Western blotting, no 
differences in bound 51 integrins were detected among control and experimental 
groups (Fig. 4.3B).  These results indicate that integrin binding activity is not altered by 
changes in actin-myosin contractility. 
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Figure 4.3 Inhibitors of MLC phosphorylation do not alter integrin binding to 
micropatterned substrates.  Cells were cultured on micropatterned substrates for 16 h and 
treated with inhibitors: Y-27632 (50µM), H-7 (500µM), HA-1077 (50µM), blebbistatin 
(250µM) for 30min. Bound integrins were cross-linked with DTSSP.  After extracting 
cells, the bound integrins were recovered and analyzed by Western blotting. (A) 
Immunofluorescence staining for α5 integrin subunit following the cross-
linking/extraction showing localization of integrins mostly at the periphery of the 
substrate.  Counter-staining with Hoechst 33258 and rhodamine–phalloidin confirmed 
complete extraction of unbound cellular components (not shown) (scale bar: 10µm).  (B)  
Relative amounts of bound α5 were quantified by Western blotting and image analysis. 
 
 To investigate the recruitment and localization of focal adhesion components to 
adhesive plaques in response to changes in actin-myosin contractility, two independent 
but complementary approaches were used.  Immunostaining for vinculin showed that 
untreated cells on micropatterned substrates formed discrete focal adhesion clusters 
throughout the adhesive island (Fig. 4.4A).  Vinculin was spatially segregated and 
constrained to the circular adhesive domain of micropatterned islands, which was 
consistent with the localization of F-actin (data not shown).  In the absence of inhibitors, 
the localization of vinculin also corresponded to that of bound 51 integrins.  These 
adhesive structures were similar to those previously observed for the same cells cultured 
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on micropatterned substrates (Gallant et al., 2005).  In general, treatment of cells with 
inhibitors of MLC phosphorylation resulted in disassembly of focal adhesions (Fig. 
4.4A).  Treatment with Y-27632 and HA-1077 resulted in minimal vinculin clustering in 
the center of the micropatterned (Fig. 4.4A).  Treatment with H-7 inhibited formation of 
vinculin-containing focal adhesions at both the center and the periphery of the adhesive 
area.  Similar changes in the localization of the structural protein talin were also observed 
(Fig. 4.4A).  In control, untreated cells, talin localized to punctuate structures constrained 
to the circular adhesive island with a preferential distribution toward the periphery of the 
adhesive domain.  Inhibitors of MLC phosphorylation disrupted talin clustering to 
various degrees with the most significant effects elicited by Y-27632.  Consistent with 
the dissolution of focal adhesions containing vinculin and talin, inhibitors of Rho-kinase 
and MLCK also blocked stress fiber formation.  The dissolution of focal adhesions by 
inhibitors of MLC phosphorylation was also confirmed by internal reflection microscopy 
(IRM) in cells adhering to FN-coated glass substrates. In IRM, areas of „close‟ (> 15 nm) 
cell-substrate contact appear as dark patches (Izzard and Lochner, 1976, 1980). Untreated 
NIH3T3 cells spread and formed close contacts with the substrate, as demonstrated by the 
dark line structures (Fig. 4.4B).  In contrast, cells treated with Y-27632 for 30 minutes 
lacked areas of close contacts between the cell membrane and the glass substrate (Fig. 
4.4B).  These results indicate that, upon addition of inhibitors of MLC phosphorylation, 
focal adhesions disassemble.  To further characterize the changes in focal adhesions, we 
used a wet-cleaving biochemical technique in which basal cell membranes containing 
focal adhesive structures are mechanically isolated and analyzed by Western blotting 
(Gallant et al., 2005; Keselowsky and Garcia, 2005).  Inhibitors of MLC phosphorylation 
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dramatically reduced the localization of vinculin and talin to focal adhesions compared to 
control cells (Fig. 4.4C and D).  There were no differences in protein levels for either 
vinculin or talin in whole cell lysates, demonstrating that the decreases in vinculin and 
talin arise from dissolution of focal adhesions.  These results are in excellent agreement 
with our immunostaining observations.  These findings indicate that inhibitors of MLC 
phosphorylation reduce adhesion strength via dissolution of focal adhesions 
independently of changes in integrin binding. 
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Figure 4.4 Inhibitors of MLC phosphorylation modulate recruitment of vinculin and talin 
to adhesive structures onmicropatterned substrates. Fibroblasts were cultured on 
micropatterned substrates for 16  h and treated with Y-27632 (50µM), H-7 (500µM), and 
HA-1077 (50µM) for 30 min.  Controls received fresh media without inhibitors. The cells 
were then fixed, extracted, and stained for vinculin, talin, or actin (scale bar: 10µm).  (B)  
Inhibition of MLC phosphorylation reduces focal adhesion formation. Fibroblasts were 
cultured overnight on glass substrates coated with10µg/ml FN and treated with indicated 
condition 30min before IRM imaging.  (C) Inhibitors of contractility modulate 
recruitment of vinculin and talin to focal adhesions.  Western blotting for vinculin and 
talin recruited to focal adhesions as analyzed by wet-cleaving method.  (D) Relative 
amounts of localized vinculin and talin were analyzed by Western blotting 
(mean±standard deviation, n=3 from two independent experiments). *P < 0.05 
relative to no treatment controls, which received fresh media without inhibitors. 
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   We next examined the role of vinculin in contractility-induced increases in 
adhesion strength.  Vinculin binds between the actin cytoskeleton and integrins and has 
been implicated in modulating focal adhesion turnover and transmitting mechanical 
forces (DeMali, 2004; Humphries et al., 2007; Mierke et al., 2008).  Using vinculin-null 
(vinc-/-) and vinculin-expressing (vinc+/+) mouse embryonic fibroblast cells (MEFs), we 
investigated the role of vinculin in contractility-mediated adhesive force generation.  
First, we confirmed that the spinning disk detachment profiles for these cells were 
consistent with those of the NIH3T3 cell lines (Fig. 4.5A).  Next, we analyzed the effect 
of the MLC phosphorylation inhibitor Y-27632 on adhesion strength.  Consistent with 
our data for NIH3T3 cells, vinculin-expressing MEFs showed a 20% reduction in 
adhesion strength upon exposure to Y-27632 for 30 minutes compared to untreated 
controls (Fig. 4.5B).  In contrast, vinculin-null MEFs showed no decrease in adhesion 
strength upon exposure to Y-27632 for 30 minutes (Fig. 4.5B).  In addition, there were no 
differences in adhesive force between vinculin-expressing cells treated with Y-27632 and 
vinculin-null cells. Immunofluorescence staining showed that bound 51 integrins were 
present throughout the contact area with a preferential localization to the periphery of the 
adhesive area (Fig. 4.5C).  Importantly, no differences in the intensity or localization of 
bound integrins could be detected between the treatment groups indicating that adhesion 
strength differences did not arise from differences in integrin binding. These findings 
indicate that vinculin expression is required for contractility-induced increases in 
adhesion strength. 
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Figure 4.5 Loss of vinculin abolishes differences in adhesion strength because of 
contractility independent of bound integrin levels.  (A)  Characteristic detachment profile 
for vinculin +/+ and vinculin -/- MEFs showing the fraction of adherent cells (f) versus 
applied shear stress (t). These cells exhibit the same detachment profiles as the NIH3T3 
cells.  (B) vinculin+/+ and vinculin -/- MEFs were cultured for 16 h on micropatterned 
surfaces and treated with Y-27632 (50µM) for 30 min prior to spinning. The no-treatment 
group received fresh media without inhibitor. Addition of inhibitor resulted in a 20% 
decrease in adhesion strength for the vinculin +/+ cells.  No differences in adhesion 
strength were detected for the vinculin -/- cells. *P < 0.03 relative to no treatment 
vinculin +/+ MEFs.  (C)  Immunoflourescence staining for α5 integrin subunit following 
cross-linking/extraction showing localization of integrins mostly at the periphery of the 
substrate (scale bar: 10µm). Treatment with Y-27632 (50µM) for 30min did not 
significantly alter integrin binding. 
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Effects of MLC phosphorylation on cell adhesion strength are FAK-dependent 
FAK is a central regulator of focal adhesions and adhesive interactions (Hanks et 
al., 1992; Ilic et al., 1995).  Furthermore, it is well established that inhibition of 
contractility reduces tyrosine phosphorylation of focal adhesion components, including 
FAK (Chrzanowska-Wodnicka and Burridge, 1996).  In addition, we recently 
demonstrated that FAK regulates the early stages of the adhesion strengthening process 
via changes in integrin activation (Michael et al., 2009).  To examine the effects of 
contractility on FAK phosphorylation in micropatterned cells, protein and 
phosphorylation levels in the presence of inhibitors of MLC phosphorylation were 
analyzed by Western blotting.  Consistent with the effects on MLC phosphorylation and 
adhesion strength, all contractility inhibitors tested reduced phosphorylation of FAK at 
the autophosphorylation site Y397 compared to untreated controls with no differences in 
total FAK levels (Fig. 4.6).  These results are in excellent agreement with previous 
observations for spread cells (Chrzanowska-Wodnicka and Burridge, 1996). 
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Figure 4.6 FAK phosphorylation is regulated by inhibitors of MLC phosphorylation.  
Cells were cultured on micropatterned substrates for 16 h and treated with inhibitors for 
30min. (A)  Western blotting for pFAK [Y397] and total FAK.  Relative amounts of (B) 
pFAK [Y397] and (C) total FAK.  The results represent two independent experiments 
with mean±standard deviation (n=3).  *P < 0.05 relative to no treatment controls that 
received fresh media without inhibitors. 
 
 The role of FAK in contractility-mediated adhesion strengthening was examined 
using Tet-FAK cells.  Tet-FAK cells are stable clones derived from FAK-/- mouse 
embryo fibroblasts engineered to express FAK under a tetracycline-responsive promoter 
(Owen et al., 1999).  In the presence of tetracycline, FAK expression is repressed and 
these cells have no FAK (FAK–); removal of tetracycline from the culture media results 
in expression of FAK (FAK+) to similar levels as wild-type fibroblasts (Fig. 4.7A).  This 
inducible system allows examination of the effects of FAK in the same cell population, 
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without non-specific effects from dominant-negative constructs or clonal variation.  Tet-
FAK cells, induced and non-induced to express FAK, adhered to fibronectin-coated 
micropatterned substrates in a similar fashion as NIH3T3 fibroblasts.  Consistent with our 
observations with NIH3T3 fibroblasts, the Rho-kinase inhibitor Y-27632 reduced MLC 
phosphorylation for Tet-FAK cells in the presence and absence of FAK without changing 
levels of total MLC (Fig. 4.7B).  Higher Y-27632 concentrations were required to reduce 
MLC phosphorylation in cells without FAK, consistent with higher expression levels of 
Rho-kinase in these cells (Chen et al., 2002).  Adhesion strength in the presence and 
absence of inhibitors of contractility was determined using the spinning disk assay.  In 
FAK+ cells, treatment with Y-27632 reduced adhesion strength by 30% compared to 
untreated cells (Fig. 4.7C).    Furthermore, treatment with Y-27632 also reduced 
localization of vinculin to focal adhesions (data not shown).  The decrease in adhesion 
strength and reduced localization of vinculin to focal adhesions are in excellent 
agreement with the 35% decrease in adhesion strength observed in NIH3T3 fibroblasts 
(Fig. 4.2A) and reductions in vinculin localization to focal adhesions (Fig. 4.4D).  
Remarkably, in FAK– cells, inhibition of MLC phosphorylation by Y-27632 did not 
reduce cell adhesion strength (Fig. 4.7C) or alter focal adhesion assembly (data not 
shown).  We note that the FAK- and FAK+ control conditions are normalized values, not 
meant for direct comparison.  These results indicate that the contractility-mediated cell 
adhesive forces require FAK expression. 
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Figure 4.7 Rho-kinase modulates cell adhesion strength via FAK.  (A)  Tet-FAK cells 
with inducible FAK expression. In the absence of tetracycline (tet), FAK expression is 
induced at high levels, while expression is repressed in the presence of tet. Tet-FAK cells 
expressing FAK (FAK+) and cells without FAK (FAK-) were cultured on micropatterned 
surfaces for 16 h and treated with Y-27632 (50 or 100µM) for 30min.  (B) Inhibitor of 
Rho-kinase reduced adhesion strength in the presence of FAK, but adhesion strength was 
not altered in the absence of FAK. *P < 0.05 relative to untreated controls of 
corresponding FAK condition. 
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Discussion 
We tested the hypothesis that actin-myosin contractility regulates cell adhesion 
strengthening via modulation of focal adhesion assembly.  While previous reports have 
shown that Rho-mediated actin-myosin contractility drives focal adhesion assembly and 
regulates cells spreading and migration (Arthur and Burridge, 2001; Chrzanowska-
Wodnicka and Burridge, 1996), the specific contributions of contractility to cell adhesion 
strengthening are not well understood.  Recent evidence supports a complex relationship 
between the state of contractility in a cell and its adhesion to the underlying matrix 
(Griffin et al., 2004).  Moreover, it is not clear how localized, directional traction forces 
involved in migration are integrated to regulate overall levels of adhesion strength.  
Although the size of focal adhesion structures shows correlation to the level of traction 
force generated (Balaban et al., 2001; Galbraith et al., 2002; Tan et al., 2003), focal 
adhesion size does not solely control adhesion strength (Tan et al., 2003), as integrin-
ligand bond strength, actin cytoskeleton architecture, and the spatiotemporal distribution 
of focal adhesions also regulate adhesion strength (Gallant et al., 2005).  In order to 
control cell adhesive area and position as well as cell shape, we examined adhesion 
strength for cells cultured on micropatterned substrates.  This approach allows for direct 
comparisons of adhesive force among experimental groups by eliminating differences in 
adhesive area/distribution and cell morphology.  Adhesions strength was quantified using 
a hydrodynamic detachment assay that applies a wide range of forces and provides 
sensitive measurements of adhesion strength (Garcia et al., 1999).  Equivalent levels of 
adhesion strength were observed between serum- and LPA-treated cultures (data not 
shown).  These values are 30% higher than those for cells cultured under serum-free 
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conditions.  Since LPA induces Rho-dependent contractility (Chrzanowska-Wodnicka 
and Burridge, 1996), this result suggests that activation of contractility enhances adhesion 
strength.  To impair actin-myosin contractility, cells were treated with pharmacological 
agents that inhibit either Rho-kinase (Y-27632) or MLCK (H-7 and HA-1077).  Due to 
their high specificity and our ability to precisely control timing and concentration of 
dosage, we use chemical inhibitors of contractility throughout this study.  We note that 
several previous studies have relied exclusively on the use of these same inhibitors (Chen 
et al., 2002; Chrzanowska-Wodnicka and Burridge, 1996; Delanoe-Ayari et al., 2004; 
Totsukawa et al., 2000).   Treatment with any of these inhibitors eliminated the serum-
induced enhancements in adhesion strength by >95% to levels indistinguishable from 
serum-free cultures.  Furthermore, these inhibitors did not reduce adhesion strength for 
cells cultured in the absence of serum, indicating that the effects of serum stimulation on 
adhesion strength were regulated by actin-myosin contractility.  Moreover, blocking 
myosin II activity with blebbistatin, which acts through a different mechanism, had 
equivalent effects on adhesion strength.  These results demonstrate that actin-myosin 
contractility is responsible for serum-induced enhancements in adhesion strength.  
Despite distinct mechanisms of action in blocking actin-myosin contractility (Rho-kinase 
vs. MLCK vs. myosin II activity), all inhibitors tested reduced adhesion strength to 
similar values.  Since all inhibitor treatments reduced MLC phosphorylation to the same 
levels, this result suggests that cell adhesion strengthening arising from serum or LPA 
stimulation is regulated by overall levels of phosphorylated MLC.  Consistent with our 
observations, Chrzanowska-Wodnicka and Burridge showed that inhibition of MLC 
phosphorylation via different mechanisms leads to inhibition of Rho-induced focal 
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adhesion assembly and stress fiber formation (Chrzanowska-Wodnicka and Burridge, 
1996). 
 Treatment with these inhibitors of contractility also resulted in the dissolution of 
focal adhesions as indicated by reduced localization of vinculin and talin to adhesion 
structures, in agreement with previous reports (Chrzanowska-Wodnicka and Burridge, 
1996).  Both inhibitors of Rho-kinase and MLCK reduced recruitment of talin and 
vinculin to adhesive plaques to similar levels, consistent with their effects on adhesion 
strength.  Although distinct roles and spatial activities for Rho-kinase and MLCK in 
spread fibroblasts have been reported (Totsukawa et al., 2000), we observed no 
significant differences between these two regulators of MLC phosphorylation, possibly 
due to the constrained micropatterned adhesive domains.  Because no differences in 
integrin binding in response to treatment with contractility inhibitors were observed, we 
attribute the contractility-mediated differences in adhesive force to changes in focal 
adhesion assembly.  Indeed, experiments with vinculin-null cells demonstrated that 
vinculin was required for the contractility-dependent differences in adhesive force. 
Recruitment of vinculin and other structural components to adhesion plaques enhances 
adhesion strength by increasing the local membrane stiffness thereby modulating bond 
stressing in the contact area (Gallant and Garcia, 2007b; Gallant et al., 2005; Goldmann 
and Ingber, 2002; Wang et al., 1993).  Interestingly, inhibition of MLC-driven 
contractility did not alter integrin binding, in terms of bound density and distribution, to 
the ECM.  In contrast to our observations, Friedland et al. recently reported that 51 
integrins do not cross-link to FN when cells were serum-starved overnight and exposed to 
inhibitors of contractility (Friedland et al., 2009).  The differences between this study and 
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the present findings may be attributed to differences in available adhesive area (fully 
spread vs. micropatterned) and the duration of exposure to both serum-free conditions 
and inhibitors.  Taken together, our results indicate that actin-myosin contractility 
modulates recruitment of cytoskeletal elements to adhesion plaques independently of 
integrin binding.  A possible mechanism for this recruitment is that contraction-driven 
forces applied to the adhesion plaque concentrates or “focuses” cytoskeletal elements 
(e.g., vinculin, talin) into clusters (Palecek et al., 1997; Wolfenson et al., 2009).  
Alternatively, application of forces to integrins or integrin-associated elements may lead 
to conformational changes favorable to the recruitment of focal adhesion proteins, such 
as vinculin (del Rio et al., 2009; Hytonen and Vogel, 2008).  In contrast to our 
observations, Chrzanowska-Wodnicka and Burridge reported that contractility also 
modulates integrin distribution in spread fibroblasts (Chrzanowska-Wodnicka and 
Burridge, 1996).  The discrepancy between this study and the present findings may be 
attributed to differences in available adhesive area (fully spread vs. micropatterned cells). 
 Inhibitors of contractility also down-regulated tyrosine phosphorylation of FAK, 
consistent with previous reports (Chrzanowska-Wodnicka and Burridge, 1996; Gallagher 
et al., 1997; Wozniak et al., 2003).  Given the central role of FAK in focal adhesion 
turnover (Ilic et al., 1995; Webb et al., 2004), we examined the role of FAK in 
contractility-mediated adhesion strengthening using cells with inducible expression of 
FAK.  In the presence of FAK, inhibitors of contractility reduced serum-induced 
adhesion strengthening as well as eliminated focal adhesion assembly, in excellent 
agreement with our observations for NIH3T3 fibroblasts.  In the absence of FAK, 
however, these inhibitors did not alter adhesion strength or focal adhesion assembly.  
  67 
 
These results indicate that actin-myosin contractility modulates adhesion strengthening 
via FAK-dependent organization of focal adhesions.  While it is well established that 
FAK plays central roles in modulating focal adhesion turnover and cell motility (Ilic et 
al., 1995; Ren et al., 2000; Webb et al., 2004), this is the first report demonstrating a 
direct role for FAK in serum-dependent increases in steady-state adhesive force.  This 
finding contrasts with the view that modulation of FAK activity (phosphorylation) is a 
downstream event following contractility-driven focal adhesion assembly (Chrzanowska-
Wodnicka and Burridge, 1996).  Our results implicate FAK in regulating adhesion 
strengthening via focal adhesion assembly.  This function is distinct from the role of FAK 
in modulating focal adhesion turnover (Webb et al., 2004) and promoting directional 
persistence in motility and reorientation in response to mechanical forces (Wang et al., 
1993).  Furthermore, the FAK-dependent effects of contractility on adhesion 
strengthening contrast the actions of FAK and contractility on cell spreading and 
migration.  Chen et al. reported that inhibition of Rho-kinase by Y-27632 in FAK-/- 
fibroblasts induced spreading and enhanced cell motility with concomitant reorganization 
of focal adhesions (Chen et al., 2002).  These authors concluded that Rho-kinase leads to 
formation of actin-myosin filaments at the periphery of FAK-/- cells, which generate 
contractile forces that reduce cell migration.  These results are consistent with the 
observation that FAK suppresses Rho activity to promote focal adhesion turnover (Ren et 
al., 2000).  The distinct effects of the interplay of contractility and FAK on migration and 
adhesion strengthening highlight the complex interactions in these two adhesive 
processes.  Finally, we note that we recently established a role for FAK in the modulation 
of initial adhesive forces via changes in integrin activation (Michael et al., 2009).  The 
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role of FAK in the contractility-mediated changes in steady-state focal adhesion assembly 
and adhesion strengthening described in the present study appears to be distinct from 
these earlier adhesive processes.   
 In summary, we demonstrate that actin-myosin contractility controls serum-
dependent cell adhesion strengthening.  Phosphorylation of MLC, either via Rho-kinase 
or MLCK, was central to the strengthening process by modulating focal adhesion 
assembly and required vinculin to achieve maximum adhesion strength.  Notably, the 
effects of MLC phosphorylation on adhesion strengthening were mediated by FAK, 
implicating this adhesion kinase in the generation of strong adhesive forces.  




CONTRIBUTIONS OF VINCULIN HEAD AND TAIL DOMAINS TO 






Vinculin, a 116 kDa focal adhesion (FA)-associated protein, plays an essential 
role in various cellular processes including migration, adhesion, and 
mechanotransduction.  Vinculin-dependent regulation of FA dynamics requires a 
conformational change involving release of strong binding between the head and tail 
domains of the protein.  Once activated, vinculin regulates FA dynamics by binding to 
talin with its head domain and F-actin with its tail domain.  While significant progress 
has been made in identifying how vinculin modulates its interactions with its numerous 
binding partners, little is known about how the protein contributes to the generation of 
adhesion force.  Using vinculin-null cells expressing wild-type and mutant vinculins 
under an inducible tetracycline promoter, we analyzed the role of vinculin in the 
generation of steady-state adhesive forces using micropatterned substrates and a 
hydrodynamic adhesion assay.  Vinculin expression increased adhesion strength by an 
average 25% in two separate vinculin-null fibroblast cell lines.  Mutations inhibiting 
strong head-tail interactions (T12), resulting in a constitutively open vinculin 
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conformation, increased adhesions strength by 50% over null controls.  Surprisingly, 
expression of tail-less vinculin (VH) increased adhesion strength to the same level as 
wild-type vinculin, suggesting that vinculin localization to FA, independently from 
binding to actin, contributes significantly to adhesive force.  It also indicates, however, 
that interactions of the tail domain with the actin cytoskeleton are required for maximal 
vinculin enhancements to adhesive force.  Analysis of fibronectin (FN)-bound integrins 
showed that both T12 and VH mutations increased the area of integrin staining by 200% 
compared to WT vinculin and null controls.  T12 and VH mutations also increased the 
amount of talin and vinculin localization to micropatterned islands over both WT and null 
controls indicating that vinculin modulates adhesion strength by increasing both integrin 
binding and focal adhesion assembly.  Adhesion strength comparisons among cells 
transiently transfected with head, tail, or a combination of head and tail demonstrated that 
the physical linkage between the head and tail domains of vinculin is critical for 
achieving maximum adhesion strength.  These findings provide new insights into the role 
of vinculin in regulating mechanical interactions between the cell and the extracellular 
matrix. 
Introduction 
Cell adhesion to extracellular matrix (ECM) provides adhesive forces mediating 
migratory processes, tissue structure and organization, and mechanotransduction 
responses (Danen and Sonnenberg, 2003; Fu et al., 2010; Hynes, 2002).  Adhesion to 
ECM components such as fibronectin and laminin, is primarily mediated by the integrin 
family of heterodimeric αβ receptors (Hynes, 2002). Integrin-mediated adhesion is a 
highly coordinated process initiated by activation and binding of the integrin to its ECM 
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ligand (Choquet et al., 1997; Faull et al., 1993; Friedland et al., 2009).  Once bound, 
integrins rapidly cluster together and generate linkages to the actin cytoskeleton mediated 
by the supramolecular structures termed focal adhesions (FA) (Geiger et al., 2001).  
Morphologically, FAs are long, flat structures typically located near the periphery of the 
cell. There, they mediate strong adhesion to the ECM by modulating force transfer 
between integrins and the actin cytoskeleton (Gallant et al., 2005; Riveline et al., 2001; 
Tan et al., 2003)(Vogel and Sheetz, 2006).  In addition to their structural role, FAs serve 
as signaling platforms that control various functions including differentiation, 
proliferation, and apoptosis (Sastry and Burridge, 2000).  Focal adhesions are highly 
dynamic structures that are actively remodeled in response to external and stimuli 
including growth factors and cues from the extracellular matrix (Greenwood et al., 1998; 
Ridley and Hall, 1992; Riveline et al., 2001)  These supramolecular structures constitute 
a central hub in the mechanostranduction machinery, exhibiting force-responsive changes 
in shape, size, and composition (Bershadsky et al., 2006).   
Vinculin, a 116 kDa F-actin binding protein, is an important regulator of FA 
dynamics (Cohen et al., 2006; Humphries et al., 2007).  In order to associate with FA, a 
conformational change in the vinculin must occur.  This change constitutes release of 
strong binding between the head and tail domains of the protein, revealing a talin binding 
site on the head domain and an F-actin binding site on the tail (Cohen et al., 2006).  
Importantly, the head and tail of the vinculin molecule are connected via a pro-line rich 
strap which spatially constrains the two portions of the protein to close proximity of each 
other, giving rise, in part, to the strong association constant between the two domains 
(Bakolitsa et al., 2004; Cohen et al., 2005).  The exact mechanism of head and tail 
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separation has yet to be fully elucidated (Cohen et al., 2005; Cohen et al., 2006; Izard et 
al., 2004). Once activated, vinculin regulates FA dynamics by binding to talin with its 
head domain and F-actin with its tail domain (Chen et al., 2005; Humphries et al., 2007).  
Activated vinculin is only found in FA (Chen et al., 2005).  Once localized to FAs, the 
molecule can transmit force between talin and F-actin (Grashoff et al., 2010).  It is 
important to note while no detectable strain is applied to the protein when it lacks a tail 
(Grashoff et al., 2010), this does not imply that this same protein cannot contribute to 
adhesion strength.  As our lab as shown (Gallant et al., 2005), only 30% of adhesion 
strength comes from focal adhesion assembly.  The other 70% is matrix-bound integrins 
(Gallant et al., 2005).  The spatial localization of the FA within the cell modulates the 
level of mechanical tension across the molecule as well as its dynamics with the adhesion 
(Grashoff et al., 2010; Wolfenson et al., 2009).  Despite extensive characterization of the 
structure of vinculin and its role in cellular processes including regulating FA dynamics 
and cell migration, the contribution of vinculin to the generation of adhesive forces has 
yet to be fully characterized.  For instance, previous work has shown that talin binding is 
critical for vinculin activation and localization to FAs (Cohen et al., 2006), however, how 
this integrin-talin-vinculin complex, independent from binding the actin cytoskeleton, 
modulates adhesion strength is unknown.  The functional importance of vinculin tail 
binding to the cytoskeleton is complex.  On one hand the integrin-talin complex, by itself, 
can bind the actin cytoskeleton directly, potentially minimizing the importance of 
vinculin connection (Critchley, 2004).  On the other, experimental work has 
demonstrated that the retrograde flow of FAs is dependent on the ability of vinculin to 
bind both talin and the contractile cytoskeleton (Humphries et al., 2007), suggesting that 
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the mechanical coupling of vinculin between integrin-talin complex and the cytoskeleton 
is important for proper focal adhesion function.   
In the present study, we use a robust, quantitative cell adhesion assay in 
combination with micropatterned substrates to control adhesive area along with cells 
engineered to express wild-type vinculin to characterize the contribution of vinculin to 
adhesion strength.  Structural mutants of the protein were used in combination with 
various biochemical techniques to characterize the functional contributions to adhesion 
strength of the head and tail domain of the protein.  We demonstrate that both the head 
and tail domain of vinculin contribute to the generation of adhesive forces and that the 
physical connection between the two in required for generation of maximum adhesion 
strength. 
 
Materials and Methods 
Cells and reagents 
Mouse embryonic fibroblasts (MEF1 and MEF2) were a kind gift from Eileen 
Adamson (Burnham Institute, La Jolla, CA).  Monoclonal antibodies against vinculin 
(clone V284; Millipore), talin (clone 8d4; Sigma) were used for immunostaining and 
Western blotting.  Monoclonal antibody against extracellular domain of β1-integrin 
(9EG7, Millipore) was used for integrin binding study.  Polyclonal antibody against β1-
integrin (ab1950, Chemicon) was used for adhesion blocking study (note this antibody is 
no longer available).   Poly(dimethylsiloxane) (PDMS) elastomers and curing agents 
were obtained from Dow Corning (Midland, MI).  
Dithiobis(sulfosuccinimidylpropionate) (DTSSP) was purchased from Pierce Chemical 
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(Rockford, IL).  Tri(ethylene glycol)-terminated alkanethiol (HO(CH2CH2O)3-
(CH2)11SH) was purchased from ProChimia Surfaces (Sopot, Poland).  All other reagents 
including hexadecanethiol (H3C(CH2)15SH) were purchased from Sigma.  Human plasma 
fibronectin was purchased from Invitrogen (Carlsbad, CA).  VH-CFP and vinT-YFP 
constructs were a kind gift from Christoph Ballestrem (The University of Manchester, 
UK). 
 
Retroviral vectors for eGFP-vinculin expression 
Retroviral plasmids pTJ66-tTA and pXF40 were previously described (Gersbach 
2006).  eGFP-C1 WT, T12, VH vinculin plasmids were a kind gift from Susan Craig 
(Johns Hopkins School of Medicine, Baltimore, MD).  One AgeI restriction site was 
inserted into the multiple cloning site of pXF40, the retroviral expression vector.  The 
oligonucleotides 5‟-AGCTTGTCAGCTACCGGTGCTACTGCA-3‟ and 5‟-
AGCTTGCAGTAGCACCGGTAGCTGACA-3‟ (AgeI sequences underlined) were 
annealed together, creating HindIII-compatible overhands at each end.  This product was 
then ligated into a linearized pXF40 vector which had been digested with HindIII.  
Finally, the eGFP- vinculin constructs were digested from the pEGFP-C1 with AgeI and 
SalI and ligated into the SalI and AgeI-digested pXF40 vector.  The pXF40-eGFP-
Vinculin vectors transcribe the eGFP-vinculin gene from the tetracycline-inducible 
promoter (Fig. 5.1A).  All vectors were verified by sequencing the ligation points.  
 
Retroviral Transduction with eGFP-Vinculin into Vinculin-null Mouse Embryonic 
Fibroblasts 
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Retroviral stocks were produced by transient transfection of helper virus-free 
Phoenix amphotropic producer cells with plasmid DNA as previously described (Byers, 
2002).  Vinculin-null mouse embryonic fibroblasts (cell lines 1 & 2) were cultured and 




 24 h prior to retroviral 
transduction.  Cells were transduced with 0.2 ml/cm
2
 of equal parts pTJ66-tTA and 
pXF40-eGFP-Vinculin retroviral supernatant supplemented with 4 µg/ml hexadimethrine 
bromide (Polybrene) and 10% fetal bovine serum, and centrifuged at 2500 r.p.m. (1200 
g) for 30 min in a Beckman model GS-6R centrifuge with a swinging bucket rotor. 
Retroviral supernatant was replaced with growth media (DMEM, 10% fetal bovine 
serum, 100U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, 1% non-essential 
amino acids, 1% sodium pyruvate).  Five days after transduction, eGFP expressing cells 
were FACS sorted, expanded, and either used for experimentation or cyropreserved in 
liquid nitrogen for later use.  Expression of vinculin constructs was verified by Western 
blot and immunofluorescence microscopy. 
 
Micropatterned substrates 
Micropatterned substrates were generated by microcontact printing of self-
assembled monolayers of alkanethiols on gold (Gallant et al., 2002).  Arrays of CH3-
terminated alkanethiol [HS-(CH2)11-CH3] circles were stamped on to Au-coated glass 
coverslips using a PDMS stamp (Sylgard 184/186 Elastomer-kit).  The remaining 
exposed areas were functionalized with a tri(ethylene glycol)-terminated alkanethiol [HS-
(CH2)11-(CH2CH2O)3-OH].  Patterned substrates were coated with human plasma 
fibronectin (2 g/mL), blocked with 1% heat-denatured BSA.  This process results in an 
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array of fibronectin-coated circular islands 5µm in diameter spaced 75µm apart to 
promote single cell attachment to each island. 
Adhesion Strength Assay 
Adhesion strength was measured using our spinning disc system (Gallant et al., 
2005; Garcia et al., 1997; Garcia et al., 1998).  Micropatterned substrates with adherent 
cells were spun in PBS + 2mM dextrose for 5 minutes at constant speed.  The applied 
shear stress (τ) is given by the formula 
            
where r is the radial position from the center of the patterned coverslip and ρ, µ, ω are the 
fluid density, viscosity, and rotational speed, respectively.  In some experiments, the 
spinning buffer was supplemented with 5% dextran to increase the fluid viscosity.  After 
spinning, cells were fixed in 3.7% formaldehyde, permeabilized in 1% Triton X-100, 
stained with ethidium homodimer-1 (Invitrogen) and counted at specific radial positions 
using a 10X objective lens in a Nikon TE300 microscope equipped with a Ludl motorized 
stage, Spot-RT camera and Image-Pro 6.3 analysis system.  A total of 61 fields (80-100) 
cells per field before spinning were analyzed and cell counts were normalized to the 
number of cells in the center of the disk.  The fraction of adherent cells (f) was then fitted 
to a sigmoid curve  
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where τ50 is the shear stress for 50% detachment and b is the inflection slope.  τ50 
characterizes the mean adhesion strength for a population of cells. 
Integrin Binding 
Integrin binding was quantified via a cross-linking/extraction  procedure (Garcia 
et al., 1999; Keselowsky and Garcia, 2005).  After rinsing cultures three times with PBS, 
DTSSP (1.0 mM in cold PBS + 2 mM dextrose) was incubated for 30 minutes to cross-
link integrins to their bound ligands.  The cross-linking reaction was quenched by 
addition of Tris (50 mM in PBS) for 15 minutes.  Uncross-linked cellular components 
were then extracted in 0.1% SDS containing 10 g/mL leupeptin, 10 g/mL aprotinin 
and 350 g/mL PMSF.  Cross-linked integrins to their bound ligands were visualized by 
immunostaining with β1 integrin-specific antibodies. 
 
Focal Adhesion Assembly 
For staining of focal adhesion components, cells were permeabilized in 
cytoskeleton-stabilizing buffer (0.5% Triton X-100: 10 mM PIPES buffer, 50 mM NaCl, 
150 mM sucrose, 3mM MgCl2, 0.5% (v/v) Triton X-100, 1 mM PMSF, 1 μg/mL 
leupeptin, 1 μg/mL aprotinin, 1 μg/mL pepstatin) for 10 min, fixed in 3.7% formaldehyde 
for 5 min, blocked in 5% goat serum, and incubated with primary antibodies against focal 
adhesion components followed by AlexaFluor-labeled secondary antibodies (Invitrogen).  
Images were captured using a Nikon Eclipse E400 equipped with a 60X APO (1.4 NA) 
TIRF objective and Spot RT Camera/Software. Focal adhesion area fractions were 
quantified using a custom MATLAB image analysis script. Briefly, original images of 
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immunostained cells were first background subtracted and then pixel intensity 
thresholded to determine focal adhesion area. 
 
Transient Transfection of Vinculin-eGFP constructs 
MEF1 cells were transfected using a Nucleofector II (Amaxa).  For each sample, 
2 million cells were resuspended in 100 µl of nucleofector solution MEF 2 with 2.5 µg of 
plasmid DNA coding for indicated vinculin-eGFP construct.  Plasmid containing cell 
suspension was loaded into Nucleofector cuvette and transfected with program T-20.  
Immediately after transfection, cells were transferred to 1.5mL centrifuge tube containing 
500 µL of pre-warmed RPMI 1640 (Invitrogen) and incubated for 15 minutes to 
minimize cell death.  Cells were then transferred into 100 mL plates containing normal 
growth media (1% P-S, 1% NEAA, 1% Sodium Pyruvate, 10% fetal bovine serum, 
Dulbecco's Modified Eagle Medium).  Cells were fluorescence active cell sorted (FACS) 
72 hours after transfection for eGFP expression and seeded onto micropatterned surfaces.  
The next day, the spinning disk assay and immunostaining were performed. 
 
Adhesion Blocking  
Cells were trypsinized from dish, quenched in serum containing media, pelleted, 
and resuspended in appropriate blocking antibody or isotype control for 15 minutes with 
gentle rocking.  Cells were seeded on micropatterned substrates for 15 min prior to 
visualization. 
Western blotting 
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Cells were washed with PBS and lysed in cold radioimmunoprecipitation assay 
(RIPA) buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 
150 mM Tris-HCl pH 7.2, 350 g/ml phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, 
10 g/ml aprotinin, and 1 mM sodium orthovanadate) for 20 min. Lysates were pipette 
up and down ~25 times to shear the DNA and then clarified by centrifugation at 10,000g 
for 10 min. Protein concentration was then determined using a Micro BCA protein assay 
kit (Pierce, Rockford, IL). Equal amounts of protein (25 µg) were boiled in Laemmli 
sample buffer (2% SDS, 10% glycerol, 100 mM DTT, 60 mM Tris-HCl pH 6.8, and 
0.001% bromophenol blue) for 10 min and separated by SDS-PAGE. Proteins were 
transferred by electrophoresis onto nitrocellulose membranes and blocked with Blotto 
(5% non-fat dry milk, 0.02% sodium azide, 0.2% Tween 20 in PBS w/o Ca2+/Mg2+) 
overnight at 4ºC.  Membranes were then incubated with appropriate antibodies in Blotto 
for 1 h at room temperature under gentle rocking.  Membranes were washed in TBS-
Tween (20 mM Tris HCl pH 7.6, 137 mM NaCl, 0.1% Tween 20) for 30 min and 
incubated in near-infrared conjugated-secondary antibodies (LiCor Biosciences, Lincoln, 
NE) for 30 minutes followed by 30 min washing in TBS-Tween.  Membranes were 
imaged with a LiCor Odyssey Imager (LiCor Biosciences, Lincoln, NE).  
Statistical Analysis 
Non-linear regression analysis was performed using SigmaPlot 2001 software 
(SPSS).  Analysis of variance (ANOVA) statistical analyses were performed using 
SYSTAT 11 software.    
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Results 
Inducible retroviral system for vinculin-eGFP expression  
 Because of the central role of vinculin in regulating adhesive interactions, we 
developed an inducible expression retroviral system to express wild-type and mutant 
vinculins in vinculin-null cells.  Our inducible system is based on the well-characterized 
tetracycline inducible promoter (Gossen et al., 1994).  In the absence of 
anhydrotetracycline (aTc), a more potent version of tetracycline, the tetracycline-
controlled transactivator (tTA) binds the tet operon and activates transcription of the gene 
of interest.  However, in the presence of sub-toxic levels of aTc, the antibiotic binds tTA, 
blocking binding of the tet operon and subsequent transactivation.  Two independent 
vinculin-null mouse embryonic fibroblast cell lines were transduced simultaneously with 
pTJ66-tTA and pXF40-WT-Vinculin-eGFP retroviral supernatants (Fig. 5.1A).  A 
significant advantage of this system is that it allows for direct comparison of the effects 
of vinculin in the same cell population.  Vinculin-eGFP positive cell populations were 
enriched by fluorescence-activated cell sorting for a minimum of three sequential rounds 
(data not shown).  Western blotting using vinculin specific antibodies confirmed 
expression of vinculin-eGFP constructs in both lines of transduced vinculin-null MEFs 
(Fig. 5.1B).  Culturing MEF2 cells in the presence of anhydrotetracycline (aTc, 
100ng/mL) significantly lowered the levels of vinculin-eGFP expression.  . We next 
examined proper localization of vinculin-eGFP to focal adhesions by fluorescence 
microscopy (Fig. 5.1C).  Briefly, MEF1 and MEF2 cells were seeded overnight on 
fibronectin (FN) coated coverslips.  The following day, cells were fixed with 4% 
paraformaldehyde, mounted on glass slides and visualized using a fluorescence 
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microscope equipped with an eGFP-specific filter cube (Fig. 5.1C).  MEF1 cells are 
smaller, migrate faster, and replicate more rapidly than MEF2 cells (data not shown).  In 
addition, the general morphology of MEF1 cells is more fibroblastic than MEF2 cells.   
In both cell lines, eGFP-vinculin properly localized to FA. 
 
Figure 5.1 Development of retroviral vinculin expression system .  (A)   Retroviral 
vectors.  The tetracycline-controlled transactivator (tTA) is constitutively expressed by 
pTJ66-tTA.  Vinculin-eGFP expression is controlled via the tet operon of pXF40-Vinc-
eGFP.  (B)  Western blot of expression for talin and vinculin in two separate vinculin-null 
mouse embryonic fibroblast (MEF) lines.  MEFs were tranduced and a stable population 
expressing vinculin-eGFP was selected.  (C)  Vinculin-eGFP properly localizes to focal 
adhesions in spread MEFs on fibronectin-coated glass substrates (scale, 10µm). 
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Micropatterned substrates to control adhesive area and cell shape 
FN-coated micropatterned substrates with dimensions smaller than a cell diameter 
in order to control adhesive area and cell shape were produced using micropatterned self-
assembled monolayers of alkanethiols on gold using standard procedures (Fig. 5.2A) 
((Gallant et al., 2002)).  First, a PDMS stamp was created by casting PDMS pre-polymer 
and curing agent into a rigid mold with recessed features.  Following heat-induced 
curing, the PDMS stamp is released from the mold.  Next, the stamp is inked with 
methyl-terminated alkanethiol and then brought into conformal contact with an Au-
coated glass coverslip.  Once in contact, the methyl-terminated alkanethiol molecules 
transfer from the stamp to the Au-surface to form a patterned self-assembled monolayer 
(SAM).  Non-printed areas of the Au-substrate are backfilled with tri(ethylene glycol)-
terminated alkanethiol to create a protein adsorption resistant SAM.  The entire substrate 
is washed and incubated with FN, which preferentially adsorbs to the patterned, methyl-
terminated SAMs (Fig. 5.2B, inset 1).  This approach allows isolation of focal adhesion 
assembly from changes in cell spreading/shape and provides for direct comparisons 
among experimental groups.  We previously reported that NIH3T3 fibroblasts remained 
viable for several days when adhering to micropatterned circular islands with dimensions 
ranging from 2 to 20 m diameter (Gallant et al., 2005).  Vinculin-null MEF1 cells, re-
expressing vinculin-eGFP maintained a round morphology, and their contact area and 
focal adhesions were constrained to the micropatterned domain of 10 m diameter circles 
(Fig. 5.2B, inset 2). The 75 m center-to-center spacing of islands restricted a single cell 
to occupy one adhesive island, preventing interactions with neighboring cells. 
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Figure 5.2 Micropatterned substrates for control of cell shape, spacing, and area.  (A)  
Workflow for generating islands of fibronectin (FN) in cell adhesion-resistant 
background.  PDMS (1:10, 186:184) is cast into a silicon template to create stamp.  
Stamp is inked with protein adsorption-promoting alkanethiol and transferred to the 
surface of an Au-coated substrate, forming a patterned self-assembled monolayer (SAM).  
Non-printed areas are backfilled with tri(ethylene glycol)-terminated alkanethiol to create 
a protein resistant SAM.  Finally, FN is passively adsorbed to surface to promote cell 
adhesion.  (B)  Islands of FN promote controlled cell adhesion.  Anti-FN antibody was 
used to visualize FN localized to microcontact printed circular islands (10µm in diameter, 
spaced 75 µm apart) (scale 75µm).  (Inset 1)  FN adsorbs specifically to patterned islands 
with undetectable amounts of protein in between (scale bar, 10µm).  (Inset 2)  Vinculin-
eGFP localized to FN-coated islands (scale bar, 10µm).   
 
Vinculin increases steady-state adhesion strength over vinculin-null controls 
 We measured the steady-state adhesion strength of MEF1 and MEF2 cell 
expressing vinculin variants using a spinning disk device that applies a range of well-
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defined hydrodynamic shear forces to adherent cells (Garcia et al., 1998) (Fig. 5.3A).  
For a particular sample, the fraction of adherent cells (f) is plotted as a function of the 
applied shear stress ().  From this detachment profile, the shear stress for 50% 
detachment (50), which represents the mean cell adhesion strength, is determined (Fig 
5.3B).  MEF1 and MEF2 cells were seeded overnight on 15 µm-diameter islands of FN. 
The following day, adhesion strength of measurements were made using the spinning 
disk apparatus.  Re-expression of vinculin-eGFP in vinculin-null MEF1 cells increased 
adhesion strength by 22% over the null controls.  Expression of vinculin-eGFP in 
vinculin-null MEF2 cells increased adhesion strength by 27%.  We verified that these 
increases in adhesion strength were due to vinculin expression by culturing stably 
expressing vinculin-eGFP MEF2 cells in 100 ng/mL of anhydrotetracycline to inhibit 
expression (Fig 5.1B).  Under these conditions, adhesion strength of MEF2 cells returned 
to the level of vinculin-null MEF2 control cells (Fig. 5.3C).  This result is consistent with 
previous results in our lab demonstrating that vinculin attributes approximately 25% to 
cell adhesion strength in NIH3T3 cells (Gallant et al., 2005). 
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Figure 5.3. Re-expression of vinculin-eGFP in vinculin-null fibroblast increases steady-
state adhesion strength.  (A)  Spinning disk assay for adhesion strength measurements.  
Cells seeded onto micropatterned substrates (Figure 5.2) are loaded into spinning disk 
machine and subjected to fluid-induced shear stress.  The applied shear stress (τ) is given 
by the formula in figure where r is the radial position from the center and ρ, µ, ω are the 
fluid density, viscocity, and rotational speed, respectively.  (B)  Characteristic 
detachment profile generated by spinning disk machine.  Cell numbers at difference 
radial positions (inverted triangles) are quantified using a motorized microscope stage 
and image analysis system.  The fraction of adherent cells is calculated by dividing the 
number of cells in each field by the total number of cells at the center of the disk, where 
negligible forces are applied.  The detachment profile (cell adherent fraction versus shear 
stress τ) is then fit (black squares connected by line) to a sigmoid curve to obtain the 
shear stress for 50% detachment, which represents the mean adhesive force.   (C)  Re-
expression of vinculin-eGFP in vinculin-null MEFs increases adhesion strength by 22% 
and 27% in MEF 1 and MEF2, respectively (* p < 0.04, # p<0.05).  Addition of 
100ng/mL of aTc reduces adhesion strength. 
 
MEF1 adhesion to FN-coated micropatterned islands is β1-integrin mediated 
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Previous work in our lab examining NIH3T3 fibroblast adhesion to FN-coated 
micropatterned islands demonstrated that the α5β1-integrin receptor mediated adhesion in 
our system (Gallant et al., 2005).  We confirmed this result with our vinculin-eGFP 
expressing MEF1 cells.  Specifically, vinculin-eGFP MEF1 cells were trypsinized, 
quenched in serum containing media, and resuspended in DPBS supplemented with 2mM 
dextrose and 100 g/mL of β1-specific blocking antibody or isotype control.  Cells were 
incubated in suspension with antibodies under gentle rocking conditions for 15 minutes.  
Cells were then seeded in serum-free media for 15 min before visualization (Fig. 5.4).  
No attached cells were visible on surfaces in the presence blocking antibody whereas 
isotype control exhibited extensive numbers of attached cells to FN-coated islands (Fig. 
5.4). 
 
Figure 5.4 Adhesion of MEFs on FN coated substrates is α5β1 integrin specific.  Cells 
were trypsinized from dish, quenched in serum containing media, pelleted, and 
resuspended in appropriate antibody for 15 minutes with gentle rocking.  (B)  Blocking 
α5β1 integrin binding to fibronectin coated islands eliminated cell attached to 
micropatterned islands (15µm diameter) compared to isotype control (A).  scale bar, 
100µm. 
 
Disruption of vinculin head-tail interaction to constitutively open conformation increases 
steady-state adhesion strength 
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Vinculin exists in the cytoplasm in a closed, inactive conformation (Fig. 5.5A).  
The 880amino acid, talin-binding head domain of the protein is tightly bound (Kd 10
-9
) to 
the F-actin binding tail (Chen et al., 2005; Cohen et al., 2006) (Fig. 5.5A).  Once 
localized to sites of focal adhesions, the molecule opens via separation of the head and 
tail domain by a yet-to-be-determined mechanism.  This activated vinculin molecule 
binds several structural and signaling FA molecules including talin and paxillin.  
Mutations to specific residues on the tail domain reduce the binding strength of the head-
tail interaction by 100-fold  (Cohen et al., 2006) (Fig.5.5A).  To examine the 
contributions of the open conformation of vinculin on adhesive forces, we generated 
vinculin-null MEF1 cells stably re-expressing head-tail interaction mutant-vinculin (T12-
eGFP).  We seeded wild-type vinculin-eGFP (WT-eGFP) and T12-vinculin-eGFP (T12-
eGFP) MEF1 cells on glass coverslips coated with FN overnight.  The following day, 
cells were fixed and mounted onto microscopy slides for visualization of vinculin 
molecules.  T12-eGFP expressing cells exhibited increased number and size of FAs 
compared to WT-eGFP expressing cells, consistent with previous reports (Cohen et al., 
2006; Humphries et al., 2007) (Fig. 5.5B).  We measured the steady-state adhesion 
strength of WT-eGFP and T12-eGFP cells on micropatterned substrates.  Compared to 
vinculin-null parental control cells, expression of WT-eGFP increased adhesion strength 
by 25% whereas T12-eGFP increased adhesion strength by 50% over null control cells 
(Fig. 5.5C).  This result indicates that the head-tail autoinhibitory interaction between the 
head and tail domain is critical for proper modulation of cell adhesion strength.  The 
increase in adhesion strength over WT could be due to increases in total amounts of 
integrin-talin complexes or higher association of T12 with integrin-talin complexes.   
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Figure 5.5.  Disruption of vinculin head-tail interaction leads to increase in number of 
focal adhesions and cell adhesion strength.  (A)  Cartoon depiction of vinculin inactive 
(closed) and active (open) state and the dissociation constant associated between each 
condition.  Notice the T12 mutant (yellow dot represents area of tail-domain containing 
mutations) has 100-fold decrease head-tail interaction (B)  WT-eGFP and T12-eGFP 
constructs expressed in MEF1 vinculin-null fibroblasts seeded on FN-coated (10ug/mL) 
FN (scale bar, 10µm).  (C)  Steady-state adhesion strength of cells on 15µm-diameter 
islands.  WT-eGFP increases adhesion strength 25% compared to null while T12-eGFP 
increases adhesion strength 50% over null (* p <0.05 compared to null).  
 
Vinculin head domain, independent of interactions with the cytoskeleton, increases 
adhesion strength 
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 When localized to focal adhesions, vinculin is in an open, active confirmation 
allowing it to transfer force (Grashoff et al., 2010).  Removal of the F-actin binding tail-
domain of vinculin eliminated force transferring ability of molecule (Grashoff et al., 
2010), presumably because the molecule needs to be anchored to binding partners at both 
the N-terminal head and C-terminal tail.    We generated vinculin-null MEF1 cells stably 
re-expressing head only-vinculin (VH-eGFP) for analyzing the effect of tail-less vinculin 
on cell adhesion strength (Fig. 5.6A).  We seeded VH-eGFP MEF1 cells on glass 
coverslips coated with FN overnight.  The following day, cells were fixed and mounted 
onto microscopy slides for visualization of vinculin molecules.  Similar to T12-eGFP 
(Fig. 5.5B), VH-eGFP expressing cells exhibited increased number and size of FAs 
compared to WT-eGFP expressing cells, consistent with previous reports (Humphries et 
al., 2007) (Fig. 5.6B).  We measured the steady-state adhesion strength of VH-eGFP cells 
on micropatterned substrates.  Compared to vinculin-null parental control cells, 
expression of WT-eGFP and VH-eGFP both increased adhesion strength by 25% (Fig. 
5.6C).  This result is surprising because it suggests that a significant amount of vinculin-
mediated adhesion force is directly attributable to binding the integrin-talin-complex and 
is not dependent on direct interaction with the actin cytoskeleton.  Furthermore, these 
results underscore the importance of connection to the cytoskeleton for full adhesion 
strength gains to be achieved.  Stated differently,  the ability of VH to form higher 
numbers of FAs does not increase adhesion strength over the WT molecule.  However,the 
T12 head-tail interaction deficient mutant increases adhesion strength by 25% over VH 
despite having similar, increased numbers of FAs, implicating the tail domain of vinculin 
is critical for cell adhesion strength.  Taken together, these results demonstrate, for the 
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first time, the critical importance of vinculin head binding to the talin-integrin complex, 
independent of vinculin interaction with the cytoskeleton, in the generation of adhesive 
forces. 
 
Figure 5.6.  Disruption of vinculin head-tail interaction leads to hypertrophied focal 
adhesions and increase in cell adhesion strength.  (A)  Cartoon depiction of vinculin head 
domain (VH) only (1-880) which lacks the F-actin binding domain.    VH mutant does 
not exhibit autoinhibitory behavior and can always bind talin.  (B)  VH-eGFP constructs 
expressed in MEF1 vinculin-null fibroblasts seeded on FN-coated (10ug/mL) FN (scale 
bar, 10µm).  (C)  Steady-state adhesion strength of cells on 15µm-diameter islands.  VH-
eGFP increases adhesion strength 25% compared to null which is same increase as WT-
eGFP (* p <0.05 compared to null).  
 
Vinculin-dependent increases in adhesion strength correlate with both increases in 
integrin binding and focal adhesion assembly 
 Two potential methods by which vinculin increases adhesion strength are (1) by 
changing the integrin bond numbers, distribution or clustering and (2) by modulating the 
recruitment and assembly of focal adhesions.    To explore these two possibilities, we 
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first determined if vinculin and vinculin mutants modulated integrin binding and 
localization to the extracellular matrix (ECM).  Previous work in our lab demonstrated 
that, in our micropatterned system, approximately 70% of steady-state adhesion strength 
is attributable to α5β1-integrin receptors binding to FN (Gallant et al., 2005).  FN-bound 
integrins were visualized using a cross-linking and extraction method(Keselowsky and 
Garcia, 2005) to covalently cross-link bound integrins to FN using the cell impermeable 
bifunctional reagent sulfo-DTSSP.  After detergent extraction of uncross-linked cellular 
components, immnostaining for β1 integrin was performed.  We previously demonstrated 
that this technique provides specific staining of bound integrin and shows equivalent 
localization  of β1 integrin to focal adhesions as conventional immunostaining (Garcia et 
al., 1999; Keselowsky and Garcia, 2005), indicating that the cross-linking/extraction 
method does not alter integrin distribution.  In addition, an advantage of this technique is 
that it removes non-specific nuclear staining that can impede visualization of the integrins 
on the micropatterned islands.  Furthermore, our abilty to control cell shape allows us to 
compare the quantities of surface-bound integrins between cell treatment groups (Gallant 
et al., 2005; Michael et al., 2009).  Immunostaining of FN-bound integrins demonstrated 
that T12 and VH vinculin mutants increase the area and intensity of integrin staining in 
compared to WT and null conditions (Fig. 5.7A).  We quantified these increases in 
integrin area (Fig. 5.7B) and intensity (Fig. 5.7C).  T12 and VH increased integrin area 
by over 200% compared to both WT and null controls.  This result demonstrates that the 
head domain of vinculin modulates the quantity and localization of the integrin-talin 
complex.  Similarly, the intensity of integrin staining of T12 and VH conditions was 
significantly higher than null control.  Interestingly, while the area of integrin staining 
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between WT and null was the same, the intensity of WT integrin staining was greater 
than the null control (Fig. 5.7C).  In addition, vinculin mutants modulated the distribution 
of integrin staining.  FN-bound integrin localized to a narrow rim on the outer edge of the 
pattern for null and WT conditions.  T12 and VH vinculin mutants exhibited a similar 
staining pattern on the rim of the adhesive area, while having a less predictable pattern of 
integrin staining in the inner portions of FN-coated islands.  Vinculin modulates the 
assembly and disassembly kinetics of focal adhesions (Cohen et al., 2006; Wolfenson et 
al., 2009), and these mutants disrupt the physiologic interactions of vinculin for focal 
adhesions, leading to mislocalized FAs and FN-bound integrins (Humphries et al., 2007; 
Mohl et al., 2009).  Taken together, these data suggest vinculin is an important modulator 
of the density and localization of FN-bound integrins. 
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Figure 5.7.  Vinculin modulates the spatial localization and intensity of surface-bound 
integrins.  (A)  Surface-bound integrins were visualized using a cross-linking and 
extraction technique, followed by immunostaining (scale bar, 5µm).  (B)  Integrin 
staining area-fraction was calculated by measuring the total area of pixels above a 
specific threshold (applied to all conditions) divided by the total cell area (n=60 cells for 
each condition).  (C)  In the same manner as (B), the mean intensity of the integrin-area 
fraction was calculated,  (* p < 0.05 compared to null condition). 
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 To investigate the recruitment and localization of focal adhesion components to 
the adhesive plaque, immunofluorescence staining was performed.  It has been 
demonstrated that talin is required for vinculin to localize to focal adhesions (Zhang et 
al., 2008).  In addition, a single amino-acid mutation in the talin binding head domain of 
vinculin (A50I) inhibits interaction with talin (Bakolitsa et al., 2004; Cohen et al., 2005).  
Furthermore, it has been suggested that vinculin directly modulates focal adhesion 
formation by directly interacting with talin (Cohen et al., 2006; Humphries et al., 2007).  
Therefore, we focused our analysis of focal adhesion components on talin and vinculin.  
MEF1 cells expressing the indicated vinculin molecule (WT, T12, and VH) were seeded 
overnight on FN micropatterned substrates.  Immunostaining for talin showed that 
expression of WT, T12, and VH vinculin variants in vinculin-null cells increases the 
amount of talin localized to focal adhesions compared to vinculin-null controls (Fig. 5.8 
A,B).  Talin was spatially segregated and constrained to the circular adhesive area of the 
micropatterned islands.  These adhesive structures were consistent with previous work in 
our lab using the same system (Gallant et al., 2005).  Also consistent with previous 
findings (Cohen et al., 2006; Humphries et al., 2007), the exposed head domain of both 
VH and T12 vinculin mutants increased talin localization to the adhesive interface 
compared to WT.  Spatial localization of vinculin strongly correlated with the talin 
localization results (Fig. 5.8 A,B).  Both VH and T12 vinculin mutants increased vinculin 
localization compared to WT control.  In addition, T12 mutant vinculin occupied a large 
percent of the patterned island than VH.  Taken together, increases in integrin binding 
and focal adhesion assembly correlate well with the corresponding increases in adhesion 
strength.   
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Figure 5.8. Vinculin modulates spatial localization and area of focal adhesions.  (A)  
Immunofluorescence staining for talin (red, top row) and vinculin-eGFP in MEF1 
fibroblasts seeded onto micropatterned substrates.  (B)  Area of talin staining as a percent 
of total cell area (* p < 0.05 compared to null).  (C)  Area of vinculin staining as a percent 
of total cell area (* p < 0.05 compared to WT). 
 
 
Physical connection between the head and tail domain of vinculin is required for 
maximum adhesion strength 
 The head domain of vinculin modulates focal adhesion assembly via direct 
binding of talin (Cohen et al., 2006; Humphries et al., 2007).  The tail domain is 
important for efficient linkage between the actin cytoskeleton and focal adhesions 
(Humphries et al., 2007).  Our results indicate that the head-tail interaction mutant, T12, 
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results in the highest level of adhesion strength.  Surprisingly, expression of F-actin 
binding deficient VH molecule results in adhesion strength comparable to WT, despite 
increases in focal adhesion assembly and integrin binding.  This result suggests that 
vinculin must bind to the cytoskeleton in order to achieve maximum adhesion strength.  
Vinculin has recently been shown to transfer force between talin and F-actin in focal 
adhesions (Grashoff et al., 2010), suggesting that the physical linkage between the head 
and tail domain might be important for generating adhesion strength.  We tested the 
hypothesis that the physical linkage between the head and tail domain of vinculin was 
required for maximum adhesion strength. 
 We transiently transfected the head domain (VH), head-tail binding deficient 
(T12), tail only (vinT) and a control eGFP vector into MEF1 vinculin-null cells (Fig. 
5.9A).  72 hrs after transfection, fluorescent cells were enriched with FAC sorting and 
seeded on micropatterned islands.  Fluorescence microscopy showed that vinculin 
mutants localized to FN-patterns in a similar way to those expressed in the retroviral 
system (Fig. 5.8A).  We co-transfected the head (VH-CFP) and tail (vinT-YFP) and, 
72hrs later, sorted for fluorescence expressing cells.  Enriched cells were immediately 
seeded onto patterns (Fig. 5.9B).  The VH-CFP and vinT-YFP molecules constitute the 
entire vinculin molecule, without the physical linkage between the head and tail domain.  
Fluorescence microscopy showed that the VH-CFP domain localizes to FN-micropatterns 
consistent with VH-eGFP (both transient and retroviral expression systems) (Fig. 5.9B).  
When co-expressed with VH-CFP, the tail domain (vinT-YFP) does not strongly co-
localize with the VH-CFP protein.  This finding is consistent with published results, as 
expression of the vinculin tail has been previously shown to decorate F-actin fibers and 
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does not strongly localize to focal adhesions (Humphries et al., 2007).  Adhesion strength 
measurements were performed to quantify the contribution of these constructs to cell 
adhesion (Fig. 5.9C).  Expression of tail only (vinT-YFP) increased adhesion strength to 
the same level of head only (VH-eGFP).  This result is unexpected as the tail domain of 
vinculin does not directly connect to the integrin-tailin complex.  Rather it was been 
shown to decorate F-actin filaments, but not to strongly localize to FAs or α-actinin rich 
lamellopida protrusions (Humphries et al., 2007; Kroemker et al., 1994; Menkel et al., 
1994).  Our own experiments with tail-only expression on a cell traction force 
measurement device indicate that even focal adhesions under high force cannot localize 
tail domain (Fig. 6.6).  There are two possible explanations for this result.  First, it is 
possible that the tail domain enhances actin cross-linking, thereby increasing the overall 
stiffness of the membrane, would more able to resist the peeling detachement mechanism 
inherent in our measurement assay (Gallant and Garcia, 2007a).  An alternative 
explanation is that increases in actin bundling modulate the size, clustering, or 
distribution of the integrin-talin complexes.   
These results implicate important roles for both the head and tail domain of 
vinculin.  Independent expression of the vinculin head and tail constructs increases 
adhesion strength to those similar to WT levels.  Surprisingly, VH accomplishes this 
independently of the action cytoskeleton, but rather, via enhancements in integrin binding 
and focal adhesion assembly.  The tail domain, by contrast, cannot directly bind the 
integrin-talin complexes, and modulates adhesion strength via a separate mechanism.  
One possible explanation is that the tail domain increases membrane stiffness via 
enhanced bundling of the actin cytoskeleton  (Mierke et al., 2008) (Le Clainche et al., 
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2010) which improves resistant to the cell detachment by peeling, mechanism inherent 
our system, by more evenly distributing detachment forces (Gallant and Garcia, 2007a).  
An alternative explanation is that vinculin tail indirectly modulates the size, location, or 
density of the integrin-talin complexes.  This is unlikely because there is little evidence to 
suggest that tail localizes to focal adhesions (Humphries et al., 2007).   
The head and tail domains of vinculin are both important for the generation of 
adhesion strength, consistent with our earlier findings.  In addition, expression of the 
head-tail binding mutant, T12-eGFP, showed the maximum adhesion strength (20% 
higher than tail-only and head-only).  Interestingly, the co-expression of the head (VH-
CFP) and tail domain (vinT-YFP) did not increase adhesion strength above those of head-
only or tail-only.  This result demonstrates that the physical connection between the head 
and tail domain represents an important functional domain of the vinculin molecule in 
adhesion force generation.      
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Figure 5.9. Physical linkage between the talin-binding head and F-actin-binding tail of 
vinculin is essential for maximum adhesion strength.  (A)  Indicated eGFP constructs 
were transiently transfected into MEF1 cells and seeded on micropatterned islands.  
Cartoon representation of vinculin constructs to show the physical linkage between the 
head and tail domains of vinculin.  (B)  Plasmids encoding for Head domain (VH-CFP) 
and tail domain (vinT-YFP) were co-transfected into MEF1 cells and seeded on 
micropatterned islands.  Cartoon representation of the lack of physical connection 
between the head and tail domain.   Line profile of VH-CFP and vinT-YFP overlay 
demonstrates that vinT does not strongly co-localize with FA-associated VH-CFP.  (C)  
Adhesion strength of indicated constructs transfected in MEF1 cells (eGFP, 210 
dyne/cm2; vinT-YFP, 342 dyne/cm2; VH-eGFP, 332 dyne/cm2; vinT-YFP + VH-CFP, 
339 dyne/cm^2; T12-eGFP 405 dyne/cm2)  (# p < 0.9 compared to T12-eGFP; * p < 0.05 
compared to T12-eGFP). 
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Conceptual model of adhesive patch force combined with collective view of adhesion 
strength, integrin binding, and focal adhesion assembly data reveals importance of 
vinculin head and tail domains in force generation 
 To better understand the effects of vinculin on adhesion strength, we summarized 
the increases over the vinculin-null condition in adhesion strength, integrin area, and FA 
assembly in Table 5.1.  Expression of the WT and VH domains increased adhesion 
strength by 25% each, while integrin area and focal adhesion assembly increased 167% 
and 172% for VH while remaining unchanged and 28% for WT, respectively.  This result 
suggests that the talin-binding head domain, VH, increases adhesion strength both by 
increasing the number of bound integrin and focal adhesion assembly.  It also suggests 
that vinculin modulates adhesion strength by its linkage to the cytoskeleton because WT 
has the same level of adhesion strength despite having lower amounts of integrin area and 
FA assembly.  This result is supported by a comparison between T12 and VH.  
Specifically, when expressed in vinculin-null MEFs, T12 and VH vinculin mutants both 
increase integrin area and FA assembly to similar levels.  T12 increases adhesion strength 
by 50% compared to vinculin-null controls, while VH increases by 25%, suggesting that 
the ability of the vinculin molecule to connect the integrin-talin-vinculin complex to the 
cytoskeleton is critical for full adhesion strength increases.  This data also suggests that 
vinculin modulates adhesion strength by increasing the number of matrix-bound integrin, 
enhancing focal adhesion assembly, and increasing the connectivity of the integrin-talin-
vinculin complex to the cytoskeleton. 
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 In order to expand our understanding of the experimental results for vinculin-
modulated adhesion strength, we present an engineering analysis of the dependence of 
adhesion strength generation on the number of bound integrins, focal adhesion assembly, 
and cytoskeleton connectivity.  The model is based on previous work in our lab which 
demonstrated excellent agreement between predicted adhesion patch force data and 
experimental results (Gallant and Garcia, 2007a).  Importantly, an advantage of the 
model is that it is based on parameters that can be measured experimentally, thus 
allowing for comparison between experimental results and model predictions. 
 We use a modified membrane peeling model that that assumes bond loading of 
matrix-bound integrin receptors is highly non-uniform and can thus be modeled by an 
exponential decay function with maximum bond forces generated at the perimeter of the 
cell which then rapidly decay towards the center (Fig. 5.10A).  The total adhesive patch 
force is calculated by the sum of individual adhesive patches consisting of bound 
integrins (B) linked together by the fraction of bonds mechanically linked by focal 
adhesion assembly (χ).  The model accounts for differences in membrane stiffness by 
modulating the sensitivity (κ) of the exponential dependence of segment loading (Fig. 
5.10B).   We populate the above parameters with a values derived from our own 
experimental data as well as data from the literature.  Specifically, the number of bound 
integrins, B, used in the model (1600 for Null and WT, and 2500 for T12 and VH) were 
  102 
 
chosen based on the integrin staining data presented in Fig. 5.7 as well as estimations of 
maximum amount of total bound integrins (3000) from Gallant 2005 (Gallant et al., 
2005).  Increases in cytoskeleton stiffness resulting from vinculin-mediated linkage of 
integrin-talin-vinculin complexes to the cytoskeleton were modeled by varying the 
exponential dependence of segment loading from 1 (no vinculin linkage, Null and VH) to 
2 (vinculin linkage, WT and T12) (Table 5.2).  Finally, we varied the levels of integrin 
bonds associated with FAs based on our experiment data of focal adhesion assembly (Fig. 
5.8).  Specifically, minimum amount of FA assembly requires one-third of integrins to be 
focal adhesion bound (Coussen et al., 2002), so we assigned this value (.33) to the 
vinculin-null condition (Table 5.2).  We assigned a focal adhesion fraction of 0.5 to WT, 
T12, and VH vinculin constructs based on our experimental results showing increased 
assembly compared to null (Table 5.2). 
 The results of the conceptual model of adhesive patch force agree well with our 
experimental results of adhesion strength.  The model predicts that expression of T12 
vinculin increases the adhesive patch force by 99.8% over the vinculin-null condition 
while expression of vinculin WT and T12 increase adhesive patch force by 50.2% and 
45.5%, respectively (Fig. 5.10C).  Our own experimental results demonstrate that WT 
and VH increase adhesion strength over null by 25% while T12 increases adhesion 
strength by 50% (Fig. 5.10D).  Comparing the predicted to the experimental results, we 
see good agreement in the relative gains in adhesion strength given by each vinculin 
construct over the vinculin-null condition.  The conceptual model is useful for 
interpreting our experimental results as it predicts that vinculin can increase adhesive 
patch for by increasing the levels of bound integrin, increasing the percent of integrins 
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bound to FAs, and by increasing the stiffness of the cytoskeleton by linking it to the 
integrin-talin-vinculin complexes.     
 
Figure 5.10. Conceptual model of adhesion strength. (A)  Conceptual model of adhesive 
patch force generation.  (B)  Exponential dependence of adhesive patch force on 
individual integrin bond strength (f), number of integrin bonds (B), fraction of bonds 
associated with FAs (χ), and exponential dependence of segment loading (κ).  (C)  
Predicted adhesive patch force gains as a percent over vinculin-null condition.  (D)  
Experimentally determined adhesion strength values with percent gains over vinculin-
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Discussion 
 We demonstrate that vinculin increases adhesion strength via enhancements in 
integrin binding/localization and focal adhesion assembly.  Mutations reducing the head-
tail interaction (T12) of the molecule result in additional increases of adhesion strength 
by further increasing the number of matrix-bound integrins as well as the assembly of 
talin and vinculin-containing focal adhesions.  Importantly, vinculin mutants lacking the 
F-actin tail domain (VH) increase adhesion strength to levels of wild-type (WT), but fail 
to achieve the same adhesion strength of T12 mutants.  This result is surprising because 
both VH and T12 exhibit similar levels of integrin binding and focal adhesion assembly, 
consistent with previous reports (Humphries et al., 2007).  The major structural 
difference between the two mutants is that T12 retains the ability to bind actin while VH 
does not.  This structural difference suggests that the binding of vinculin to the 
cytoskeleton is essential for maximum adhesion force generation, independent of integrin 
binding and focal adhesion assembly. High-resolution, 3-D imaging of the nanoscale 
architecture of the adhesive plaque demonstrated that vinculin head domain localizes to 
talin in the region sandwiched between with integrins below and the actin cytoskeleton 
above (Kanchanawong et al., 2010).  While the authors did not directly measure the 
location of the tail domain of vinculin, it is reasonable to assume that the molecule orients 
itself such that the tail binds the actin cytoskeleton.  The assumption is supported by 
direct evidence that vinculin tail is required for efficient linkage of adhesive complexes to 
the actin cytoskeleton (Humphries et al., 2007).  In addition, vinculin tail efficiently 
cross-links and bundles actin filaments (Janssen et al., 2006; Menkel et al., 1994).  
Therefore, one possible explanation for our finding that the tail domain is required for 
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maximum adhesion strength is that discrete focal adhesions are mechanically coupled 
together by their vinculin-dependent linkage to the cytoskeleton.  These mechanically 
coupled adhesions would thereby increase adhesion strength by requiring that all linked 
adhesions fail simultaneously.  A similar model has been proposed to describe focal 
adhesion-induced increases in adhesion strength (Gallant and Garcia, 2007a).  In this 
model, independent clusters of integrins adhesive patches are linked together by focal 
adhesions.  Mechanically linked adhesive patches fail simultaneously, instead of 
individually, thereby increasing cell resistance to detach forces.  Stated briefly, we 
hypothesize that vinculin is required for efficient coupling of the focal adhesions to the 
actin cytoskeleton and that this coupling to the cytoskeleton mechanically links discrete 
focal adhesions, thereby increasing the resistance to adhesion strength.  Implicit in this 
model is the importance of the physical linkage between the head and tail domain of the 
vinculin molecule.  Importantly, this simple model also explains why head adhesion 
strength to above null, but not the levels of actin-binding T12.    
We therefore hypothesized that the proline-rich strap that physically links the 
talin-binding head and actin-binding tail is essential for achieving maximum adhesion 
strength.  We directly tested this hypothesis by co-transfecting vinculin head and tail 
constructs.  The constructs themselves represent the entire vinculin molecule in which the 
head and tail domains are not linked together.  Consistent with our model, co-expression 
of head and tail constructs were not able to achieve the same level of achieve strength as 
the full-length, head-tail interaction mutant, T12.  Importantly, transfecting cells with 
only the tail of vinculin increased adhesion strength compared to the null condition.  This 
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result independently supports our view that the actin-bundling tail of vinculin is 
important for generating adhesion strength.  
Finally, we employed the use of a previously validated (Gallant and Garcia, 
2007a) conceptual model of adhesion force generation.  Based on a modified membrane 
peeling model, it assumes bond loading of matrix-bound integrin receptors is highly non-
uniform and can thus be modeled by an exponential decay function with maximum bond 
forces generated at the perimeter of the cell which then rapidly decay towards the center 
(Fig. 5.10A).  The model considers the affects of numbers of bound integrins, extent of 
focal adhesion assembly, and cytoskeleton modulated membrane stiffness.  Using 
parameters derived from our experimental data as well as the adhesion strength literature, 
the predicted adhesive patch force increases over null condition for each of the vinculin 
constructs (WT, T12, and VH) correlated strongly with our experimental results (Fig. 
5.10C,D).  The model predictions thus support our interpretation of the experimental 
data; namely, that vinculin increases adhesion strength by a combination of increasing the 
number of integrin-FN bonds, increasing FA assembly, and by physically linking the 
integrin-talin-vinculin complex to the cytoskeleton.   
In conclusion, we have demonstrated that vinculin increases adhesion strength 
when expressed in vinculin-null cells.  We showed that the gains in adhesion strength are 
attributable to increases in FN-bound integrins and focal adhesion assembly.  Reduction 
in the strength of the head-tail interaction (T12) increases FN-bound integrins, focal 
adhesion assembly, and adhesion strength 25% higher than wild-type vinculin.   
Expression of the head domain only (VH) also increases FN-bound integrins and focal 
adhesion assembly, however, the adhesion strength is the same as wild-type.  We 
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hypothesized that vinculin tail linkage to the cytoskeleton allows for maximum adhesion 
strength by mechanically linking independent focal adhesions.  Adhesion studies with co-
expression of independent head and tail domains support this model and demonstrate that 
the physical connection between the head and tail is essential for achieving maximum 
adhesion strength.  
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CHAPTER 6 





 The conversion of mechanical forces into chemical signals is a fundamental 
cellular process that occurs at supramolecular structures called focal adhesions (FAs).  
Integrin-mediated adhesion to the extracellular matrix gives rise to the assembly of force-
sensing FAs.  Despite considerable characterization of the structural and morphological 
changes to FAs in response to force, the exact molecular interactions that are responsible 
for the behavior remain unknown.  Recent experimental and computational evidence has 
suggested that the binding interaction between talin and vinculin might be regulated by 
force.  Direct evidence that force-induced binding interactions are relevant, in-cellulo, 
does not yet exist.  Herein, we present a novel approach for characterizing the force-
dependent dynamics of focal adhesion associated proteins.  Using this system, we 
demonstrate that the dynamics of vinculin recruitment to FAs are linearly dependent on 
the level of force applied to the focal adhesion.  Specifically, as force applied to the FA 
increases, so too does the stability of vinculin in the FA.  This result supports a simple 
model in which cytoskeleton generated tension across vinculin modulates its binding 
interactions within FAs.  However, we also provide surprising evidence to contradict this 
model by showing that the force applied to focal adhesions modulates the dynamic 
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recruitment of vinculin, independent of its interaction with the cytoskeleton.  We 
therefore hypothesize that cytoskeleton generated force applied across talin exposes one 
or more vinculin binding sites (VBS) that are important for the force-dependent dynamics 
of recruitment of vinculin to FAs.   Taken together, a model emerges wherein vinculin 
dynamics are dually regulated both by direct application of cytoskeleton generated force 
across vinculin and by force induced exposure of VBS on talin. 
 
Introduction 
Cells have the remarkable ability to detect and respond to their mechanical 
environment (Sastry and Burridge, 2000).  Forces, both externally and internally 
generated, modulate cell behavior and structure.  Apart from a few well characterized 
systems, how mechanical forces are converted into chemical signals remains largely 
undefined (Riveline et al., 2001).  Focal adhesions are supramolecular structures that 
serve both as sites of force transfer between the extracellular matrix and cytoskeleton and 
as signaling platforms (Balaban et al., 2001; Riveline et al., 2001).  These dynamic, 
complex structures link ECM-bound, transmembrane integrin receptors to the actin 
cytoskeleton.  The processes by which FA grow, modulate shape and size, and control 
disassembly are all modulated by the stiffness of the underlying substrate (Sniadecki et 
al., 2007; Vogel and Sheetz, 2006).  While it is clear that force modulates focal adhesions 
the structure and function of FAs, the manner in which they accomplish this is unclear.   
The integrin-talin-vinculin complex serves as a critical force bearing linkage 
between the internal cytoskeleton and the extracellular matrix (Gallant et al., 2005; 
Humphries et al., 2007; Zhang et al., 2008).  Previous work in our own lab has 
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demonstrated the importance of this complex to the generation of adhesion forces 
(Gallant et al., 2005).  Importantly, all three of the individual proteins in the complex 
have been shown to respond to force.  For example,  integrin-ligand catch-bonds describe 
how integrins increase their affinity for ligands upon application of force (Kong et al., 
2009).  In addition, molecular dynamics of force application to both vinculin and talin 
have uncovered potential force-regulating binding pathways that could mediate 
interactions between the two proteins (Golji and Mofrad, 2010; Lee et al., 2008).  By 
applying tensile force to individual talin molecules, del Rio et al provided physical 
evidence that cryptic vinculin-binding sites become exposed which promote binding of 
the vinculin head domain (del Rio et al., 2009).  While these studies on isolated, single 
molecules provide insight into the potential force induced interactions of vinculin and 
talin, how these relationships unfold in the context of a living cell is unclear.   
Herein we present a novel approach for measuring the force mediated, dynamic 
behavior of focal adhesion-associated proteins.  We used micro post array deflections 
substrates to measure cell the force transferred across individual focal adhesions (Fu et 
al., 2010; Tan et al., 2003).  Simultaneously, we measured the dynamic behavior of 
fluorescent vinculin molecules expressed in vinculin-null mouse embryonic fibroblasts 
using fluorescence recovery after photobleaching.  This unique approach allowed us to 
characterize, for the first time, the force-dependent behavior of vinculin in focal 
adhesions.  We show that vinculin turns over more rapidly in focal adhesions under low 
force compared to slower vinculin recovery at high forces.  Importantly, we show that the 
relationship between applied focal adhesion force and vinculin recovery is linearly 
dependent.  This result supports a simple model in which cytoskeleton generated tension 
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across vinculin modulates its binding interactions within FAs.  However, we also provide 
surprising evidence to contradict this model by showing that the force applied to focal 
adhesions modulates the dynamic recruitment of vinculin, independent of any direct 
application of cytoskeleton generated force to the molecule.  Combined, these results 
suggests a model by which the dynamic recruitment of vinculin to focal adhesions is, at 
least in part, modulated by force applied to other focal adhesions molecules. 
 
Materials and Methods 
Reagents 
 Human plasma fibronectin (FN), fetal bovine serum, Dulbecco‟s modified eagle‟s 
medium (high glucose) and Dulbecco‟s phosphate buffered saline (dPBS) were obtained 
from Invitrogen (Carlsbad, CA).  Poly(dimethylsiloxane)(PDMS) elastomers and curing 
agents were obtained from Dow Corning (Midland, MI).  Inhibitors (blebbistatin and 
calyculin-A) were purchased from Sigma-Aldrich (St. Louis, MO).  1,1'-dioleyl-3,3,3',3'-
tetramethylindocarbocyanine methanesulfonate (Δ9-DiI) was purchased from  Invitrogen.  
F127 Pluronic was purchased from Sigma-Aldrich (St. Louis, MO).   
 
Fabrication Flow - Micro post array deflection substrates (mPADs) 
mPAD devices were fabricated in accordance with the protocol developed by the 
laboratory of Chris Chen, University of Pennsylvania (Yang et al., 2011). PDMS molds 
were created by pouring 1:10 Sylgaurd 184 (Dow Corning) over the silanized mPAD 
silicon master (a kind gift from JP Fu lab, Univeristy of Michigan) and placed in a 110ºC 
convection oven for 1 hour.  Molds were allowed to cool and then were peeled from the 
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masters and cut into individual device molds.  These individual molds were then UVO 
cleaned (Jelight Model 342) for 10 minutes to promote the formation -OH groups on the 
surface of the mold.  The molds were then transferred into a desiccator and 100 µL (two 
or three drops) of (tridecafluoro-1,1,2,2,-tetrahydrooctyl1)-1-trichlorosilane (Sigma) was 
placed onto a microscope slide.  The desiccator was then placed under constant vacuum 
for 24 hours to promote the vapor phase silanization of the surface.  After the molds were 
silanized, a drop of 1:10 PDMS was put on top of the each mold, and degassed for 30 
minutes.  During degassing, round 22mm coverslips were treated with atmospheric 
plasma to promote covalent bind to the coverslip prior to peeling.  After the molds were 
sufficiently degassed to remove air bubbles, the molds were inverted onto the plasma 
treated coverslips and placed into a 110ºC convection oven for 20-24 hours.  After full 
curing, the final device was created by peeling the mold, and inverting it into a bath 
EtOH followed by sonication to recover collapsed posts.  Devices were dried under 
super-critical CO2 (Tousimis PVT-3) to generate fully recovered mPAD devices.  
Detailed protocol can be found in Nature Protocols ((Yang et al., 2011)). 
 
mPAD Device Prep Flow 
  A standard silicon wafer was silianized and 1:30 Sylguard 184  was cast on top 
and cured at 110ºC for minimum one hour.  PDMS was peeled from the wafer and cut 
into square stamps smaller than the device area.  Stamps were cleaned by sonication in 
EtOH for 5 min to remove loose PDMS flakes and debris.  Under cell culture hood, 
stamps were dried under stream of N2.  Next, human plasma fibronectin (50 µg/mL) was 
adsorbed on the top surface of the stamps for 1 hour.  Excess FN was removed by 
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submerging stamps in ultrapure diH2O.  Stamps were removed and dried under a gentle 
stream of N2.  Fully recovered mPAD devices were then trimmed with razor blade to 
remove excess PDMS.  mPAD devices were then treated with UVO cleaner for 10 min to 
prepare surface for microcontact printing.  FN-coated, flat PDMS stamps, were then 
inverted onto the tops of mPAD devices (transfer of FN from flat stamp to top of the 
mPAD occurs within seconds).  Without removing the FN stamp, mPAD devices were 
transfer into 100% EtOH, to allow for removal of the FN stamp without collapsing posts.  
Devices were then washed as follows:  1X 70% EtOH, 4X diH2O, and transferred into 
5µg/mL Δ9-DiI and incubated for 1 hour.  Devices were then washed 2X in 100% H2O 




free)  and transferred to 1-2% Pluronics 
F127 (Sigma) and incubated for 30 minutes to block non-specific protein adsorption.  




free) three times.  Prepared 
devices were transferred into 6 well plates and seeded with cells at a density of 20,000 
cells /cm
2
.  After waiting until the desired number of cells have seeded, non-seeded cells 
were washed off.  Cells were allowed to spread on mPADs overnight. 
 
Fluorescence recovery after photobleaching (FRAP) 
 A confocal microscope (Nikon C1) and an inverted microscope (Nikon TE 300) 
equipped with a Coherent Sapphire solid-state 488 laser under the control of Nikon EZ-
C1 software were used for FRAP experiments.  Cells were seeded overnight on FN-
coated mPAD devices.  Prior to imaging, devices were mounted into a on-stage incubator 
(LiveCell II, Pathology Devices, Westminster, MD) maintained 100% humidity and 5% 
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C02.  A custom microscope enclosure was used to thermally stabilize the microscope at 
37ºC.  
FRAP experiments were performed as follows.  Cell-seeded mPAD device was 
loaded into an Attofluor cell chamber (Invitrogen, Carlsbad, CA) and allow to equilibrate 
for >20 minutes.  A 60X APO TIRF (1.49 NA) objective (Nikon) was used for imaging.  
Initial fluorescence intensity was measured using low laser power (1.5-2.5%) followed by 
photobleaching of a 0.85um-diameter circle inside FAs at 10% laser power for 1 zoomed 
pass (256x256 pixels inside of circle).   The fluorescent recovery was monitored every 7-
seconds (10 seconds for VH and T12) until plateau in recovery was reached (5 pre-bleach 
and 30 post-bleach images).  Images were imported into MATLAB and background 
subtraction and bleaching correction were applied to data from the region of interest.  
Curves were fit to single exponential recovery model by assuming a reaction dominated 
system and disregarding any effects of diffusion. 





where τ, r, and D represent the first-order characteristic recovery time, radius of 
photobleached spot, and the diffusion constant of the molecule (Sprague and McNally, 
2005).  We used a bleach radius of 0.42µm which, for BSA (77kDa, D=66 µm/s
2
), yields 
as recovery time of 0.001s.  While vinculin (116 kDa) is larger than BSA, it is unlikely 
that the diffusion effects contribute to our recovery measurements.  This assumption is 
supported by recent results showing similar recovery time for different size 
photobleached spots, indicating a reaction, not diffusion, dominated system (Wolfenson 
et al., 2009). 
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Post deflection measurements were taken immediately following FRAP recovery.  
Specifically, the top and bottom of the posts were sequentially captured.  ImageJ (NIH, 
Bethesda, MD) was used to measure the center-to-center distance between the top and 
bottom of the tethered post.  The resulting force was calculated using Euler-Bernoulli 
beam theory approximation where 






   
in which F,E,D,L, and υ are the bending force, Young‟s modulus, pillar diameter, pillar 
height, and resulting deflection of the post (Yang et al., 2007). 
For studies with chemical inhibitors, appropriate concentration (1M blebbistatin 
and 0.1nM calyculin-A) were added to samples 30 minutes prior to measurements. 
 
Retroviral vectors for eGFP-Vinculin WT  
Retroviral plasmids pTJ66-tTA and pXF40 were previously described ((Gersbach 
et al., 2007)).  eGFP-C1 WT vinculin and eGFP-C1 VH vinculin plasmids were a kind 
gift from Susan Craig.  One AgeI restriction site was inserted into the multiple cloning 
site of pXF40, the retroviral expression vector.  The oligonucleotides 5‟-
AGCTTGTCAGCTACCGGTGCTACTGCA-3‟ and 5‟-
AGCTTGCAGTAGCACCGGTAGCTGACA-3‟ (AgeI sequences underlined) were 
annealed together, creating HindIII- compatible overhands at each end.  This product was 
then ligated into a linearized pXF40 vector which had been digested with HindIII.  
Finally, the eGFP-vinculin constructs were digested from the pEGFP-C1 with AgeI and 
SalI and ligated into the SalI and AgeI-digested pXF40 vector.  The pXF40-eGFP-
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Vinculin WT and VH vectors transcribe the eGFP-vinculin gene from the tetracycline-
inducible promoter.  All vectors were verified by sequencing the ligation points.  
 
Retroviral Transduction of eGFP-Vinculin vectors into Vinculin-null Mouse Embryonic 
Fibroblasts 
Retroviral stocks were produced by transient transfection of helper virus-free 
ΦNX amphotropic producer cells with plasmid DNA as previously described ((Byers et 
al., 2002)).  Vinculin-null mouse embryonic fibroblasts, a kind gift from Eileen 




 24 h 
prior to retroviral transduction.  Cells were transduced with 0.2 ml/cm
2
 of equal parts 
pTJ66-tTA and pXF40-eGFP-Vinculin retroviral supernatant supplemented with 4 
µg/mL hexadimethrine bromide (Polybrene) and 10% fetal bovine serum, and centrifuged 
at 2500 r.p.m. (1200 g) for 30 min in a Beckman model GS-6R centrifuge with a 
swinging bucket rotor. Retroviral supernatant was replaced with growth media (DMEM, 
10% fetal bovine serum, 100U/mL penicillin G sodium, 100 g/mL streptomycin sulfate, 
1% non-essential amino acids, 1% sodium pyruvate).  Five days after transduction, eGFP 
expressing cells were FACS sorted, expanded, and either used for experimentation or 
cyropreserved in liquid nitrogen for later use.  Expression of vinculin constructs was 
verified by Western blot and immunofluorescence microscopy (data not shown). 
 
Results 
Microfabriated post array detector system (mPADs) for cell traction force measurements 
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 Cells continually sense, respond to, and modulate their mechanical environment.  
Physical cues from the extracellular matrix control cell behaviors such as migration, 
proliferation, and differentiation.  Here, we use microfabricated post array detector 
systems (mPADs), originally developed by the laboratory of Chris Chen (U of 
Pennsylvania), to measure cell generated traction forces (Fu et al., 2010).  The effective 
stiffness of each device can be tuned by changing the height of the individual pillars and 
there exists a well-characterized library of devices that are freely available 
(http://www.seas.upenn.edu/~chenlab/micropostform.html).  We screened devices with 
three different spring constants (3.8, 11.5, 18.2 nN/µm) in order to determine the stiffness 
range that promoted optimal cell spreading and traction force generation with our 
vinculin-null mouse embryonic cells (MEF1) (data not shown).  Based on these results, 
we chose mPADs with a post height of 6.1µm, post diameter of 1.83µm, and post-to-post 
spacing of 2µm, resulting in an effective spring constant of 18.2 nN/µm.  We seeded 
vinculin-null MEF1 cells re-expressing vinculin-eGFP (Fig. 5.1) on FN-coated mPADs 
(Fig. 6.1A).  Devices were mounted in an Attofluor cell chamber (Invitrogen), allowed to 
equilibrate for > 20 min on a Nikon TE300 equipped with an environmental chamber, 
and then imaged.  Vinculin-eGFP co-localized to the tops of FN-coated posts (Fig. 6.1A) 
and showed preferential focal adhesion formation at the distal edges of the cell, consistent 
with MEF1 vinculin-eGFP on glass surfaces (Fig. 5.1C).  An image of both the base and 
top of posts was captured and a composite image of post bottom (blue), post top (red), 
and vinculin-eGFP was created (Fig. 6.1B).  Cell traction forces applied at each post were 
calculated by importing the image stack into a custom MATLAB code, kindly provided 
by Chris Chen (Fig. 6.1C).  Consistent with previous results, maximum cell traction 
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forces occurred at the distal edge of the cell and were directed, in general, towards the 
center of the cell (Fu et al., 2010).  Cells remained viable on mPADs for greater than 4 
days.  
 
Figure 6.1.  Microfabricated post array detector system (mPADs).  (A)  Vinculin-null 
MEF re-expressing WT-eGFP-vinculin spread on mPADs coated with 50µg/mL of 
fibronectin (FN).  (B)  Merged images of post bottom (blue), post top (red), spread cell 
expressing vinculin-eGFP.  Notice how FAs localize with tops of posts. (scale bar, 
20µm).  (C)  Blue arrows representing cell traction force applied to each post.  Forces 
range for 0-20nN.    
 
Fluorescent recovery after photobleaching measurements on mPADs 
 Focal adhesions (FAs) sense and respond to mechanical forces (Balaban et al., 
2001).  The exact molecular mechanism involved in this process, however, have yet to be 
determined.  Vinculin exists in the cytoplasm in an inactive, autohibited conformation 
(Chen et al., 2005).  At sites of focal adhesions, the protein adopts an open, active 
conformation and binds to talin and F-actin (Chen et al., 2005).  The interaction between 
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talin and vinculin has recently been proposed as a potential force-sensing unit (Golji and 
Mofrad, 2010).   Physical evidence for force-mediated interaction between vinculin and 
talin has recently been demonstrated (del Rio et al., 2009).  In addition, fluorescence 
recovery after photobleaching has recently shown that the dynamic behavior of vinculin 
in focal adhesions is dependent on the spatial location of the adhesion (Wolfenson et al., 
2009).  Furthermore, a force sensing vinculin molecule demonstrated that vinculin 
experiences higher forces at the leading edge of migratory cells compared to the rear, 
retracting edge (Grashoff et al., 2010).  To date, however, there exists no direct evidence 
that the dynamics of vinculin recruitment to FA are modulated by the force.   
 To address this issue, we combined fluorescent recovery after photobleaching 
(FRAP) with traction force measuring mPAD devices to characterize how the dynamics 
of vinculin recruitment to FA are modulated by force across focal adhesions.  We 
measured the dynamics of vinculin-eGFP containing focal adhesions subjected to various 
levels of force (Fig. 6.2A).  Vinculin-eGFP containing adhesions localized directly to the 
tops of individual posts.  Importantly, only focal adhesions that were distinctly associated 
with a single post were analyzed, allowing for direct measurement of force applied across 
an adhesion (Fu et al., 2010). Arrowheads adjacent to the focal adhesion subjected to 
FRAP indicate the magnitude and direction of cell traction force (Fig. 6.2A).  Raw 
images of time series FRAP recovery demonstrate minimal x-y-z stage drift and minimal 
focal adhesion rearrangement during recovery (Fig. 6.2A).  Normalized percent recovery 
data was computed from raw images using custom MATLAB code.  Normalize recovery 
curves demonstrated the capability of our technique to measure the dynamics of vinculin 
recruitment to FA independent of the amount of force applied to the post (Fig. 6.2B). 
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Figure 6.2.  Fluorescence recovery of vinculin-eGFP on mPADs.  (A)  Time-lapse 
recovery of vinculin-eGFP focal adhesions on mPADs.  FAs (arrow heads) were 
bleached and recovery was monitored (scale bar = 10µm).  (B)  Normalized recovery for 
low (5.7nN, filled circles), moderate (13.0nN, filled triangles), and high (38.2nN, filled 
squares) forces as measured by deflection of FA-associated post.   Lines indicate first-
order fit to respective data points. 
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Vinculin association with focal adhesions increases as force applied across focal 
adhesion increases 
Using our novel technique of combining FRAP and traction-force measuring 
devices, we characterized the dynamics of vinculin in focal adhesions under different 
amounts of force.  A total of 22 focal adhesions in three independent experiments were 
used to generate the force versus normalized recovery time in Fig. 6.3.  We restricted our 
analysis to focal adhesions that were both located on the periphery of the cell and 
confined, geometrically, to only one post.  In addition, we performed only one FRAP per 
cell in order to minimize any confounding effects resulting from exposure to the  
photobleaching laser power.  This approach allowed for the most direct measurement of 
focal adhesion applied force.    A linear least-squares fit was applied to the data 
describing the relationship between vinculin dynamics and applied force through a focal 
adhesion (slope significantly non-zero, p <0.0001).  At small forces, vinculin exhibits 
faster dynamics, while at higher forces, focal-adhesion associated vinculin exchanges 
more slowly.   
We tested the force-dependent correlation of vinculin recovery by modulating the 
contractile state of the cytoskeleton.  Specifically, we used well-characterized chemical 
inhibitors to modulate the amount of myosin II mediated cytoskeleton tension.  First, 
vinculin-eGFP cells were exposed to a low concentration (1µM) of the myosin II ATPase 
inhibitor blebbistatin (Straight et al., 2003).  This concentration relaxed cell generated 
contractile forces without complete abrogation of focal adhesions, thus allowing us to 
perform FRAP measurements (Fig. 6.4, blue dotted line).  Importantly, previous reports 
in the literature have indicated that this concentration is sufficient to modulate cell 
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migration speed and adhesion strength (Gupton and Waterman-Storer, 2006).  Vinculin-
eGFP recovery times in cells exposed to blebbistatin demonstrated excellent agreement 
with our previous results.  Next, cell traction force was increased by addition of low-
levels of calyculin-A (100 pM), a potent type II phophatase inhibitor that blocks myosin 
II phosphatase, thus enhancing myosin II activity (Ishihara et al., 1989).  A histogram of 
measured forces revealed that this concentration reduced the occurrence of low traction 
forces (Fig. 6.4A, red dotted line).  The characteristic recovery time as a function of force 
closely matched our results in the absence of inhibitors (Fig. 6.4B).  Taken together, the 
data indicate that the rate of vinculin dissociation in focal adhesion decreases as the 
amount of force applied across the adhesion increases.  This result supports a simple 
model by which cytoskeleton generated tension across vinculin modulates its binding 
interactions within FAs. 
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Figure 6.3.  Disassociation of vinculin from focal adhesions slows as force applied to 
adhesion increases  (A)  Characteristic recovery time, τ(1/2), plotted as a function of FA 
force.  Each data point represents a single FA recovery in a cell.  Fitted line is a linear 
least squares fit with the slope (s/nN) and r-squared values indicated.  Slope is 
significantly non-zero,  p < 0.0001.   
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Figure 6.4.  Effect of myosin II-mediated contractility modulating drugs on vinculin 
turnover.  (A)   Histogram of the number of FRAP experiments performed at specified 
force.  Cells were treated with the myosin II  inhibitor, Blebbistatin (1µM), to reduce 
cytoskeleton generated tension.  Likewise, cells were treated with calyculin A (0.1nM) to 
enhance myosin II activity.  (B)  Vinculin WT-eGFP characteristic recovery time plotted 
as a function of measured FA force in the absence (black dots) or presence of myosin II 
inhibiting (Blebbistatin, blue squares) or enhancing (calyculin A, red triangles) drugs.   
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Force dependent recovery of vinculin head domain 
 To test the model that cytoskeleton generated tension across vinculin modulates 
its binding interactions within FAs, we investigated the force dependent behavior of the 
talin-binding vinculin head domain which lacks the actin-binding tail domain.  
Importantly, this mutant cannot bind the actin cytoskeleton directly and, therefore, force 
from the cytoskeleton cannot be transferred through the protein (Grashoff et al., 2010).  
We predicted that this mutant form of vinculin would exhibit force-independent dynamic 
interactions with focal adhesions.   
MEF1 cells expressing VH-eGFP (Fig.5.6) were seeded onto FN-coated mPADs 
and allowed to adhere overnight (Fig. 6.5).  Similar to WT-eGFP, VH-eGFP expressing 
MEF1 cells spread and developed contractile forces on mPADs.  In addition, VH-eGFP 
demonstrated the ability to form punctuate focal adhesions that were localized and 
constrained to individual posts (Fig. 6.5A).  Compared to VH-eGFP cells seeded on FN-
coated glass substrates, cells on mPADs spread to a similar area and exhibited a similar 
increase in the number of focal adhesions, compared to WT.  We measured the force 
dependent characteristic recovery time of VH-eGFP constructs and plotted the results 
against the previously captured WT-eGFP data (Fig. 6.5B).  In contrast to WT, recovery 
of VH-eGFP was more dependent on the applied force across the adhesion.  A linear 
least-squares fit had a slope of 16.7 (s/nN) compared to 2.69 (s/nN) for WT.  More 
experiments with the VH-eGFP mutant are required to confirm this preliminary finding. 
This is result is very surprising as it provides evidence to contradict the simple 
model that the dynamics of vinculin recruitment to focal adhesions are solely dependent 
upon the cytoskeleton-generated tension applied through the molecule.  It also suggests 
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that, in addition to the auto-inhibition head-tail interaction (Cohen et al., 2005), the force 
applied to the focal adhesion is also an important regulator of vinculin dynamics.  We 
show that the force applied to focal adhesions can modulate the dynamic recruitment of 
vinculin, independent of any direct application of cytoskeleton generated force to the 
molecule.  A simple explanation for this result is that cytoskeleton generated force is 
transferred to focal adhesion causes force-induced exposure of vinculin binding sites on 
talin.   
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Figure 6.5.  Force dependent turnover of head and tail domain of vinculin.  (A)  
Vinculin-null MEF1 cells expressing VH-eGFP on glass (left) and on mPAD device 
(right) (scale 20µm).  (B)  Characteristic recovery times of VH-eGFP compared to WT-
eGFP.  (C)  Parameters of lines for linear least squares fit of WT-eGFP and VH-eGFP 
data. 
 
Dynamics of vinculin-tail domain cannot be correlated to force measurements 
 Because the focal adhesion dynamics of the talin-binding head domain (VH-
eGFP) showed a strong relationship to the applied force, we next analyzed the force 
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dependent dynamics of the vinculin tail (vinT-YFP).  The head and tail domain of 
vinculin cooperate to maintain vinculin in an inactive confirmation until it becomes 
activated at sites of focal adhesions.  In addition the tail domain contains the F-actin 
binding domain.  We transfected YFP-conjugated tail domain (vinT-YFP) into vinculin-
null MEF1 cells and seeded cells onto glass substrates (Fig. 6.6A).  vinT-YFP localized 
to the distal tips of cell extensions and also bound to F-actin fibers, consistent with 
previous findings (Humphries et al., 2007).  When seeded onto mPADs, vinT-YFP did 
not localize to discrete posts.  In contrast, vinT-YFP failed to form any punctuate 
adhesions and, instead, exhibited diffuse staining in the cytoplasm (Fig. 6.6B).  In 
addition, vinT-YFP did not localize (green arrow) to the distal areas of the cell, where 
maximum post deflection occurred (red arrow showing deflected post) (Fig. 6.6B, inset).  
We captured a total of 6 FRAP measurements of the vinT-YFP molecule.  VinT-YFP 
exhibited a fast average characteristic recovery time of 20 s.  These recovery times are 
consistent with previous reports (Humphries et al., 2007) suggesting proper vinT-YFP 
function.   
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Figure 6.6.  Recovery time versus force measurements cannot be made with vinculin-
tail-YFP (vinT-YFP) because vinT-YFP structures span multiple posts and do not 
localize to deflected posts.  (A)  vinT-YFP construct transiently transfected into MEF1 
vinculin-null cells and seeded onto FN-coated glass coverslips.  Cells were fixed with 4% 
paraformaldehyde and mounted on glass slides followed by visualization with 
fluorescence microscopy (scale 10µm).  vinT-YFP transfected MEF1 cells seeded onto 
mPAD device.  In constrast to WT-eGFP and VH-eGFP vinculin molecules, the vinT-
YFP does not localize to tops of mPAD pillars (scale bar 10µm).  In addition, inset shows 
how the vinT-YFP signal attenuates (green arrowhead) approximated 4µm from distal 
deflected posts(red arrow head) (scale 10 µm).  
 
Discussion 
 We describe a novel method for measuring force-mediated focal adhesion protein 
dynamics.  This method utilizes micro arrayed posts to measure cell generated traction 
force.  This approach to measuring force is advantageous because it decouples changes in 
substrate stiffness from changes in the microscopic material properties that could affect 
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ligand binding and cell response (Fu et al., 2010).  In addition, the technique allows for 
direct measurement of the force applied to focal adhesions that co-localize with 
individual posts (Fu et al., 2010; Tan et al., 2003).  We measured the dynamic behavior 
of focal adhesion associated proteins using fluorescence recovery after photobleaching.  
The fluorescence recovery of vinculin protein inside of the photobleached spot is 
dominated by the exchange dynamics between vinculin binding partners, rather than 
diffusion (see materials and methods).  By measuring the time-dependent intensity of 
fluorescence recovery, we determined the characteristic recovery time of FA-associated 
vinculin as a function of force.  The assumption that recovery is dominated by 
interactions with binding partners is reasonable based on our own calculations (see 
methods) and, in addition, recent results that used difference sizes of photobleached spots 
demonstrated that both vinculin and talin dynamics in focal adhesions are reaction-
dominated (Wolfenson et al., 2009).  We used this novel technique to test the hypothesis 
that the dynamics of vinculin recruitment to focal adhesions are modulated by force. 
 We first demonstrate that vinculin-null cells engineered to express vinculin-eGFP 
constructs adhere and spread on mPADs (Fig. 6.1).  Importantly, vinculin-eGFP localizes 
to the tops of posts and form discrete, independent focal adhesions.  This observed FA 
morphology allows us to directly measure the force applied through individual focal 
adhesions.  In contrast, expression of the head-tail interaction vinculin mutant (T12) 
developed adhesions that spanned multiple posts, making it difficult to interpret how 
measured forces across multiple deflected forces are distributed through the focal 
adhesion. 
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 We next demonstrate the feasibility of our measurement technique across of range 
of posts deflections (Fig. 6.2).  Vinculin association and accumulation within focal 
adhesions can be modulated by substrate stiffness and changes in substrate strain 
(Balaban et al., 2001).  Therefore, it is possible that at low force levels, vinculin 
accumulation might be beneath detectable threshold for proper execution of FRAP 
experiments.  Time-lapse images of low-force focal adhesions e demonstrate that, indeed, 
our technique has the sensitivity to measure recovery times on posts transferring as low 
as 1 nN of force (Fig. 6.2A).   The % recovery of fluorescence signal for three different 
forces (Fig. 6.2B) demonstrates that our system is capable of a FRAP measurements 
through a wide-range of forces.   
 We next characterized the force-dependent recruitment of vinculin to focal 
adhesions.  Our results indicate that the dynamic recruitment of vinculin to focal 
adhesions is linearly correlated to applied FA force.  Specifically, at low force, vinculin 
protein exhibits the fastest recovery time, while at high force, the recovery time is 
significantly slower (higher characteristic recovery time) (Fig. 6.3).  To confirm the 
results, we used chemical inhibitors to modulate the overall traction force of the cell.  
Small amounts of blebbistatin (1µM) reduced the contractile state of the cell (Fig. 6.4A), 
but did not fully dissolve vinculin containing focal adhesions.  Force versus recovery 
time measurements of focal adhesion exposed to blebbistatin correlated well with our 
non-inhibitor data (Fig. 6.4B), suggesting that force modulates vinculin dynamics within 
focal adhesion.  Cytoskeleton tension was increased by the addition of low levels of 
calyculin-A (100 pM).  This potent type II phophatase inhibitor blocks myosin II 
phosphatase, thus enhancing myosin II activity (Ishihara et al., 1989) and cell traction 
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forces.  At low concentrations (<1nM), calyculin-A is relatively specific for myosin II 
phosphatase, thus minimizing the chance our results are due to off target effects that 
might regulate vinculin dynamics (Gupton and Waterman-Storer, 2006).  Force-recovery 
curves for calyculin-A enhanced contractility demonstrated close alignment with our 
inhibitor-free data.    Taken together, these data constitute the first in-cellulo 
measurements describing the relationship between applied force and the dynamics of 
vinculin recruitment to FAs.  These results provide important, new insights into the 
mechanotransduction pathways that allow FAs to be force responsive. 
The data also indicate that vinculin dynamics in focal adhesion are linearly related 
to the amount of force applied across the adhesion.  In agreement with previous reports 
(Balaban et al., 2001; Grashoff et al., 2010), this result supports a simple model by which 
cytoskeleton generated tension applied across vinculin modulates its binding interactions 
within FAs.   
To test the model that cytoskeleton generated tension across vinculin modulates 
its binding interactions within FAs, we investigated the force dependent behavior of the 
talin-binding vinculin head domain which lacks the actin-binding tail domain.  
Importantly, this mutant cannot bind the actin cytoskeleton and, therefore, force from the 
cytoskeleton cannot be transferred through the protein (Grashoff et al., 2010).  We 
predicted that this mutant form of vinculin would exhibit force-independent dynamic 
interactions with focal adhesions.  In contrast to WT, recovery of the vinculin head 
domain was more dependent on the applied force across the focal adhesion.  A linear 
least-squares fit had a slope of 16.7 (s/nN) compared to 2.69 (s/nN) for WT.   
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This is result is very surprising as it provides evidence to contradict the simple 
model that the dynamics of vinculin recruitment to focal adhesions are solely dependent 
upon the cytoskeleton-generated tension applied through the molecule.  We show that the 
force applied to focal adhesions can modulate the dynamic recruitment of vinculin, 
independent of any direct application of cytoskeleton generated force to the molecule.   
A simple explanation for this result is that cytoskeleton generated forces are transferred 
to focal adhesions causing force-induced exposure of vinculin binding sites (VBS) on FA 
proteins that, in turn, modulate vinculin dynamics.  Recent experimental results 
supporting this model demonstrated that applied tensile force to individual talin 
molecules exposed cryptic vinculin-binding sites which promoted binding of the vinculin 
head domain (del Rio et al., 2009).  We therefore hypothesize that cytoskeleton generated 
force applied across talin exposes one or more vinculin binding sites (VBS) that are 
important for the force-dependent dynamics of recruitment of vinculin to FAs.  Taken 
together, a model emerges wherein vinculin dynamics are regulated both by direct 
application of cytoskeleton generated force across vinculin and by force induced 
exposure of VBS on talin. Further experimental data are required to confirm or reject this 
hypothesis.     
 Finally, we demonstrate a technical limitation of measuring force-induced focal 
adhesion dynamics.  Specifically, we transfected vinculin tail domain in vinculin-null 
cells and attempted to measure the relationship between force and tail dynamics.  As can 
be seen from cells seeded on traction force measurement devices, vinculin tail did not 
localize to individual posts.  Therefore, while we could measure both force and recovery 
time, the two could not be correlated because the tail did not localize to discrete posts 
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(Fig. 6.6).  It is interesting to note that while the vinculin tail did localize to focal 
adhesions when cells are plated on glass, we did not observe the same localization on the 
mPADs.  The stiffness difference between the two substrates could account for this 
observation.  A possible explanation is that there is a minimum amount of force applied 
to a FA in order to recruit the vinculin tail.  Further experiments, beyond the scope of this 
work, are required to test this hypothesis. 









The objective of this project was to analyze the role of vinculin in the cell 
adhesion strengthening process.  Our central hypothesis was that vinculin modulates 
adhesion strength via regulating the size and/or composition of the integrin-talin-vinculin 
complex.  The rationale for this project was that use of a novel combination of 
biochemical reagents and engineering techniques along with quantitative and sensitive 
adhesion strength measurements would provide new insights into how the structure of 
vinculin contributes to cell adhesion strength.  
In Chapter 3 we demonstrate that focal-adhesion kinase (FAK) regulates steady-
state adhesion strength by regulating vinculin localization to focal adhesions.  In Chapter 
4, we demonstrate that actin-myosin contractility controls cell adhesion strengthening 
through focal adhesion kinase and the assembly of vinculin-containing focal adhesions.  
Both of these results pointed to vinculin as being an important regulator of adhesive 
force.  Indeed, previous work in our lab suggested that the assembly of vinculin-
containing focal adhesions contributed 20% to the generation of cell adhesion strength.     
Chapter 5 describes our efforts to further analyze the role of vinculin in the cell 
adhesion strengthening process.  As such, we demonstrate that vinculin increases 
adhesion strength when expressed in vinculin-null cells.  We show that the gains in 
adhesion strength are attributable to increases in FN-bound integrins and focal adhesion 
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assembly.  Reduction in the strength of the head-tail interaction (T12) increased FN-
bound integrins, focal adhesion assembly, and adhesion strength 25% higher than wild-
type vinculin.   Expression of the head domain only (VH) also increases FN-bound 
integrins and focal adhesion assembly, however, the adhesion strength is the same as 
wild-type.  We hypothesized that vinculin tail linkage to the cytoskeleton allows for 
maximum adhesion strength by mechanically linking independent focal adhesions.  
Adhesion studies with co-expression of independent head and tail domains support this 
model and demonstrate that the physical connection between the head and tail is essential 
for achieving maximum adhesion strength.  A logical extension of this work would 
involve a more detailed study of the structure-function relationship of the integrin-talin 
complex.  Using similar approaches as were applied in Chapter 5, a detailed study of how 
the functional domains of talin and integrin modulate adhesion strength would provide 
new insight to better understand how the integrin-talin-vinculin complex works together 
to generate cell adhesion strength. 
Chapter 6 describes the development of a novel approach for characterizing the 
force-dependent dynamics of focal adhesion associated proteins.  Using this system, we 
demonstrate that the dynamics of vinculin recruitment to FAs are linearly dependent on 
the level of force applied to the focal adhesion.  This result supports a simple model in 
which cytoskeleton generated tension across vinculin modulates its binding interactions 
within FAs.  However, we also provide surprising evidence to contradict this model by 
showing that the force applied to focal adhesions modulates the dynamic recruitment of 
vinculin, independent of its interaction with the cytoskeleton.  Combined, these results 
suggests a model by which the dynamic recruitment of vinculin to focal adhesions is, at 
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least in part, modulated by force applied to other focal adhesions molecules.  A natural 
extension of this work would be to further test the hypothesis that the dynamic 
recruitment of vinculin to focal adhesions is modulated both by direct application of force 
across the vinculin molecule and by force applied to other focal adhesion molecules.  An 
obvious candidate is the vinculin and integrin binding molecule, talin.  Talin has been 
implicated in stretch induced exposure of vinculin binding sites (VBS).  Future studies 
could focus on characterizing the specific role of these VBS in force-mediated dynamic 
recruitment of vinculin to focal adhesions.  
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